Bruce Brew

Head of Neurosciences Program and Peter Duncan Neurosciences Unit St Vincent's Centre for Applied Medical Research and Dept of Neurology St Vincent's Hospital
Conjoint Professor

Research Interests:
HIV related dementia: the pathogenesis in terms of neurotropic viruses and the host response in particular excitotoxins and other neurotoxins produced by the kynurenine pathway. Collaboration exists with several centres in the US, Italy, and Sweden. Alzheimer's disease and neural stem cells

Broad Research Areas:
Neurology, Neuroscience, HIV - AIDS, Clinical Research, Neurodegenerative Diseases

Qualifications:
MBBS Syd, DMedSci (Syd Uni), DSc (UNSW) FRACP FAAN

Society Memberships & Professional Activities:
Fellow of the Royal Australasian College of Physicians, Member of Australian Association of Neurologists, Appointed Corresponding Fellow of American Association of Neurologists , New York Academy of Sciences , American Association for the Advancement of Science, Member of the Australasian Society of HIV Medicine, International AIDS Society, Member of The Research Group on CSF of the World Federation of Neurology, Member of The Neuroimmunology Research Group of the World Federation of Neurology, President of the International Society for Neurovirology

Specific Research Keywords:
Neurology, Neuroscience, Neuroimmunology, Neurochemistry, Neural Stem Cells

Publications

Journal articles
add
Zeng G; Penninkilampi R; Chaganti J; Montagnese S; Brew BJ; Danta M, 2020, 'Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy.', Neurology, vol. 94, pp. e1147 - e1156, http://dx.doi.org/10.1212/WNL.0000000000008899
2020
Bukhari W; Clarke L; O’Gorman C; Khalilidehkordi E; Arnett S; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Ramanathan S; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonnell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt J; Slee M; Taylor BV; Willoughby E; Wilson RJ; Brilot F; Vincent A; Waters P; Broadley SA, 2020, 'The clinical profile of NMOSD in Australia and New Zealand', Journal of Neurology, http://dx.doi.org/10.1007/s00415-020-09716-4
2020
Brew BJ; McArthur JC, 2020, ''A man is as old as his arteries' (attributed to Thomas Sydenham, the English Hippocrates)', AIDS, vol. 34, pp. 637 - 639, http://dx.doi.org/10.1097/QAD.0000000000002414
2020
Brew BJ; Barnes SL, 2019, 'The impact of HIV central nervous system persistence on pathogenesis', AIDS, vol. 33, pp. S113 - S121, http://dx.doi.org/10.1097/QAD.0000000000002251
2019
Cysique LA; Brew BJ, 2019, 'Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection', , vol. 165, pp. 71 - 82, http://dx.doi.org/10.1016/B978-0-444-64012-3.00006-X
2019
Barnes SL; Brew BJ, 2019, 'Acute cerebellar ataxia after Epstein-Barr virus infection', Neurology: Clinical Practice, vol. 9, pp. 505 - 506, http://dx.doi.org/10.1212/CPJ.0000000000000659
2019
Cysique LA; Brew BJ, 2019, 'Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm', Journal of NeuroVirology, vol. 25, pp. 710 - 721, http://dx.doi.org/10.1007/s13365-018-0706-5
2019
Zhai S; McColl C; Mahajan A; Lueck CJ; Brew BJ, 2019, 'Recurrent HIV-associated posterior reversible encephalopathy syndrome', Neurology: Clinical Practice, vol. 9, pp. 478 - 480, http://dx.doi.org/10.1212/CPJ.0000000000000602
2019
Jacobs KR; Lim CK; Blennow K; Zetterberg H; Chatterjee P; Martins RN; Brew BJ; Guillemin GJ; Lovejoy DB, 2019, 'Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau', Neurobiology of Aging, vol. 80, pp. 11 - 20, http://dx.doi.org/10.1016/j.neurobiolaging.2019.03.015
2019
Aung HL; Kootar S; Gates TM; Brew BJ; Cysique LA, 2019, 'How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection?', European Geriatric Medicine, vol. 10, pp. 227 - 238, http://dx.doi.org/10.1007/s41999-019-00164-6
2019
Cysique LA; Jugé L; Lennon MJ; Gates TM; Jones SP; Lovelace MD; Rae CD; Johnson TP; Nath A; Brew BJ, 2019, 'HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection', AIDS, vol. 33, pp. 433 - 441, http://dx.doi.org/10.1097/QAD.0000000000002076
2019
Chaganti J; Marripudi K; Staub LP; Rae CD; Gates TM; Moffat KJ; Brew BJ, 2019, 'Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications', AIDS, vol. 33, pp. 1843 - 1852, http://dx.doi.org/10.1097/QAD.0000000000002300
2019
Brew BJ; McArthur J, 2019, 'Distinguishing cognitive impairment from HIV-associated neurocognitive disorder versus substance use?', AIDS, vol. 33, pp. 1943 - 1944, http://dx.doi.org/10.1097/QAD.0000000000002292
2019
Brew BJ; Paul R, 2019, 'HIV-associated neurocognitive disorder, extracellular vesicles and gender: Vive la difference?', AIDS, vol. 33, pp. 1795 - 1796, http://dx.doi.org/10.1097/QAD.0000000000002273
2019
Warhurst S; Rofe CJ; Brew BJ; Bateson D; McGeechan K; Merki-Feld GS; Garrick R; Tomlinson SE, 2018, 'Effectiveness of the progestin-only pill for migraine treatment in women: A systematic review and meta-analysis', Cephalalgia, vol. 38, pp. 754 - 764, http://dx.doi.org/10.1177/0333102417710636
2018
Zhai S; Brew BJ, 2018, 'Progressive multifocal leukoencephalopathy', Handbook of Clinical Neurology, vol. 152, pp. 123 - 137, http://dx.doi.org/10.1016/B978-0-444-63849-6.00010-4
2018
Radd-Vagenas S; Duffy SL; Naismith SL; Brew BJ; Flood VM; Fiatarone Singh MA, 2018, 'Effect of the Mediterranean diet on cognition and brain morphology and function: A systematic review of randomized controlled trials', American Journal of Clinical Nutrition, vol. 107, pp. 389 - 404, http://dx.doi.org/10.1093/ajcn/nqx070
2018
Sutherland EJ; Brew BJ, 2018, 'Human Immunodeficiency Virus and the Nervous System', Neurologic Clinics, vol. 36, pp. 751 - 765, http://dx.doi.org/10.1016/j.ncl.2018.07.002
2018
Cysique LA; Jugé L; Gates T; Tobia M; Moffat K; Brew BJ; Rae C, 2018, 'Covertly active and progressing neurochemical abnormalities in suppressed HIV infection', Neurology: Neuroimmunology and NeuroInflammation, vol. 5, http://dx.doi.org/10.1212/NXI.0000000000000430
2018
Smail RC; Brew BJ, 2018, 'HIV-associated neurocognitive disorder', Handbook of Clinical Neurology, vol. 152, pp. 75 - 97, http://dx.doi.org/10.1016/B978-0-444-63849-6.00007-4
2018
Haggstrom L; Brew B; Sutton I; Tisch S, 2018, 'Vestibular symptoms as the presenting feature of progressive supranuclear palsy', Journal of Clinical Neuroscience, vol. 50, pp. 74 - 76, http://dx.doi.org/10.1016/j.jocn.2018.01.021
2018
Brew BJ, 2018, 'Introduction to HIV infection and HIV neurology', Handbook of Clinical Neurology, vol. 152, pp. 1 - 2, http://dx.doi.org/10.1016/B978-0-444-63849-6.00001-3
2018
Brew BJ; Garber JY, 2018, 'Neurologic sequelae of primary HIV infection', Handbook of Clinical Neurology, vol. 152, pp. 65 - 74, http://dx.doi.org/10.1016/B978-0-444-63849-6.00006-2
2018
Bundell C; Brunt SJ; Cysique LA; Brusch A; Brew BJ; Price P, 2018, 'The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy', Pathology, vol. 50, pp. 313 - 316, http://dx.doi.org/10.1016/j.pathol.2017.10.017
2018
Nichols M; Gates T; Soares J; Moffat K; Rae C; Brew B; Cysique L, 2018, 'Brain atrophic signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection', AIDS, vol. 33, pp. 55 - 66, http://dx.doi.org/10.1097/QAD.0000000000002042
2018
Wilson MR; O'Donovan BD; Gelfand JM; Sample HA; Chow FC; Betjemann JP; Shah MP; Richie MB; Gorman MP; Hajj-Ali RA; Calabrese LH; Zorn KC; Chow ED; Greenlee JE; Blum JH; Green G; Khan LM; Banerji D; Langelier C; Bryson-Cahn C; Harrington W; Lingappa JR; Shanbhag NM; Green AJ; Brew BJ; Soldatos A; Strnad L; Doernberg SB; Jay CA; Douglas V; Josephson SA; DeRisi JL, 2018, 'Chronic meningitis investigated via metagenomic next-generation sequencing', JAMA Neurology, vol. 75, pp. 947 - 955, http://dx.doi.org/10.1001/jamaneurol.2018.0463
2018
Asahchop EL; Branton WG; Krishnan A; Chen PA; Yang D; Kong L; Zochodne DW; Brew BJ; Gill MJ; Power C, 2018, 'HIV-associated sensory polyneuropathy and neuronal injury are associated with miRNA-455-3p induction', JCI insight, vol. 3, http://dx.doi.org/10.1172/jci.insight.122450
2018
Anderson AM; Croteau D; Ellis RJ; Rosario D; Potter M; Guillemin GJ; Brew BJ; Woods SP; Letendre SL, 2018, 'HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau', Journal of Neuroimmunology, vol. 319, pp. 13 - 18, http://dx.doi.org/10.1016/j.jneuroim.2018.03.007
2018
Wright EJ; Grund B; Robertson KR; Cysique L; Brew BJ; Collins GL; Poehlman-Roediger M; Vjecha MJ; Penalva De Oliveira AC; Standridge B; Carey C; Avihingsanon A; Florence E; Lundgren JD; Arenas-Pinto A; Mueller NJ; Winston A; Nsubuga MS; Lal L; Price RW, 2018, 'No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts', AIDS, vol. 32, pp. 985 - 997, http://dx.doi.org/10.1097/QAD.0000000000001778
2018
Lee JM; Tan V; Lovejoy D; Braidy N; Rowe DB; Brew BJ; Guillemin GJ, 2017, 'Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis', Neuropharmacology, vol. 112, pp. 346 - 364, http://dx.doi.org/10.1016/j.neuropharm.2016.05.011
2017
Bukhari W; Prain KM; Waters P; Woodhall M; O'Gorman CM; Clarke L; Silvestrini RA; Bundell CS; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brown M; Brownlee WJ; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Killpatrick T; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell R; Mason DF; McCombe PA; Pender MP; Pereira JA; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt JDE; Slee M; Taylor BV; Willoughby E; Wilson RJ; Vincent A; Broadley SA, 2017, 'Incidence and prevalence of NMOSD in Australia and New Zealand', Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 632 - 638, http://dx.doi.org/10.1136/jnnp-2016-314839
2017
Cysique LA; Gott C; Gates TM; Dermody N; Brew BJ, 2017, 'Cognitive Change Trajectories in Virally Suppressed HIV-Infected Individuals Indicate High Prevalence of Disease Activity', PLoS One, vol. 12, http://dx.doi.org/10.1371/journal.pone.0171887
2017
Ellero J; Lubomski M; Brew B, 2017, 'Interventions for Neurocognitive Dysfunction', Current HIV/AIDS Reports, vol. 14, pp. 8 - 16, http://dx.doi.org/10.1007/s11904-017-0346-z
2017
Kamminga J; Lal L; Wright EJ; Bloch M; Brew BJ; Cysique LA, 2017, 'Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use', Current HIV/AIDS Reports, vol. 14, pp. 83 - 92, http://dx.doi.org/10.1007/s11904-017-0349-9
2017
Lennon MJ; Jones SP; Lovelace MD; Guillemin GJ; Brew BJ, 2017, 'Bcl11b-A critical neurodevelopmental transcription factor-roles in health and disease', Frontiers in Cellular Neuroscience, vol. 11, http://dx.doi.org/10.3389/fncel.2017.00089
2017
Cysique LA; Soares JR; Geng G; Scarpetta M; Moffat K; Green M; Brew BJ; Henry RG; Rae C, 2017, 'Erratum to: White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration (Journal of NeuroVirology, (2017), 23, 4, (539-547), 10.1007/s13365-017-0524-1)', Journal of NeuroVirology, vol. 23, pp. 548 - 549, http://dx.doi.org/10.1007/s13365-017-0542-z
2017
Cysique LA; Soares JR; Geng G; Scarpetta M; Moffat K; Green M; Brew BJ; Henry RG; Rae C, 2017, 'White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration', Journal of NeuroVirology, vol. 23, pp. 539 - 547, http://dx.doi.org/10.1007/s13365-017-0524-1
2017
Gott C; Gates T; Dermody N; Brew BJ; Cysique LA, 2017, 'Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity', PLOS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0171887
2017
Brew B; Carroll A, 2017, 'HIV-associated neurocognitive disorders: Recent advances in pathogenesis, biomarkers, and treatment', F1000Research, vol. 6, http://dx.doi.org/10.12688/f1000research.10651.1
2017
Brew BJ; Cysique L, 2017, 'Does HIV prematurely age the brain?', The Lancet HIV, vol. 4, pp. e380 - e381, http://dx.doi.org/10.1016/S2352-3018(17)30108-X
2017
Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ, 2017, 'Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases', Neuropharmacology, vol. 112, pp. 373 - 388, http://dx.doi.org/10.1016/j.neuropharm.2016.03.024
2017
Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA, 2017, 'Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure', Journal of Clinical and Experimental Neuropsychology, vol. 39, pp. 753 - 767, http://dx.doi.org/10.1080/13803395.2016.1263282
2017
Lim CK; Bilgin A; Lovejoy DB; Tan V; Bustamante S; Taylor BV; Bessede A; Brew BJ; Guillemin GJ, 2017, 'Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression', Scientific Reports, vol. 7, http://dx.doi.org/10.1038/srep41473
2017
Chaganti JR; Heinecke A; Gates TM; Moffat KJ; Brew BJ, 2017, 'Functional connectivity in virally suppressed patients with HIV-associated neurocognitive disorder: A resting-state analysis', American Journal of Neuroradiology, vol. 38, pp. 1623 - 1629, http://dx.doi.org/10.3174/ajnr.A5246
2017
Crossley KM; Agnihotri S; Chaganti J; Rodriguez ML; McNally LP; Venna N; Turbett SE; Gutman M; Morey A; Koralnik IJ; Brew BJ, 2016, 'Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals', Journal of NeuroVirology, vol. 22, pp. 541 - 545, http://dx.doi.org/10.1007/s13365-015-0419-y
2016
Bloch M; Kamminga J; Jayewardene A; Bailey M; Carberry A; Vincent T; Quan D; Maruff P; Brew B; Cysique LA, 2016, 'A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review', Clinical Infectious Diseases, vol. 63, pp. 687 - 693, http://dx.doi.org/10.1093/cid/ciw399
2016
Braidy N; Rossez H; Lim CK; Jugder BE; Brew BJ; Guillemin GJ, 2016, 'Characterization of the Kynurenine Pathway in CD8+ Human Primary Monocyte-Derived Dendritic Cells', Neurotoxicity Research, vol. 30, pp. 620 - 632, http://dx.doi.org/10.1007/s12640-016-9657-x
2016
Brew BJ, 2016, 'Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment?', AIDS, vol. 30, pp. 2379 - 2380, http://dx.doi.org/10.1097/QAD.0000000000001225
2016
Gates TM; Cysique LA; Siefried KJ; Chaganti J; Moffat KJ; Brew BJ, 2016, 'Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder', AIDS, vol. 30, pp. 591 - 600, http://dx.doi.org/10.1097/QAD.0000000000000951
2016
Gray LR; Cowley D; Welsh C; Lu HK; Brew BJ; Lewin SR; Wesselingh SL; Gorry PR; Churchill MJ, 2016, 'CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies', Molecular Psychiatry, vol. 21, pp. 574 - 584, http://dx.doi.org/10.1038/mp.2015.111
2016
Gray LR; Brew BJ; Churchill MJ, 2016, 'Strategies to target HIV-1 in the central nervous system', Current Opinion in HIV and AIDS, vol. 11, pp. 371 - 375, http://dx.doi.org/10.1097/COH.0000000000000278
2016
Nadel J; O'Dwyer E; Emmanuel S; Huang J; Cheruvu S; Sammel N; Brew B; Otton J; Holloway CJ, 2016, 'High-risk coronary plaque, invasive coronary procedures, and cardiac events among HIV-positive individuals and matched controls', Journal of Cardiovascular Computed Tomography, vol. 10, pp. 391 - 397, http://dx.doi.org/10.1016/j.jcct.2016.07.018
2016
Lennon MJ; Jones SP; Lovelace MD; Guillemin GJ; Brew BJ, 2016, 'Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis?', Neurotoxicity Research, vol. 29, pp. 201 - 207, http://dx.doi.org/10.1007/s12640-015-9573-5
2016
Brunt SJ; Cysique LA; Lee S; Burrows S; Brew BJ; Price P, 2016, 'Short communication: Do cytomegalovirus antibody levels associate with age-related syndromes in HIV patients stable on antiretroviral therapy?', AIDS Research and Human Retroviruses, vol. 32, pp. 567 - 572, http://dx.doi.org/10.1089/aid.2015.0328
2016
Lovelace MD; Varney B; Sundaram G; Franco NF; Ng ML; Pai S; Lim CK; Guillemin GJ; Brew BJ, 2016, 'Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis', Frontiers in Immunology, vol. 7, http://dx.doi.org/10.3389/fimmu.2016.00246
2016
Walker S; Brew B, 2016, 'Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis', Journal of Clinical Neuroscience, vol. 31, pp. 217 - 218, http://dx.doi.org/10.1016/j.jocn.2016.03.001
2016
Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2016, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults', Journal of NeuroVirology, vol. 22, pp. 56 - 65, http://dx.doi.org/10.1007/s13365-015-0368-5
2016
Anesten B; Yilmaz A; Hagberg L; Zetterberg H; Nilsson S; Brew BJ; Fuchs D; Price RW; Gisslén M, 2016, 'Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV', Neurology: Neuroimmunology and NeuroInflammation, vol. 3, http://dx.doi.org/10.1212/NXI.0000000000000300
2016
Tobia M; Jones S; Lovelace M; Rae C; Cysique L; Brew B, 2016, 'Reduced cellular energy as a potential marker of HIV brain latency related neuropathogenesis: a pilot study', JOURNAL OF NEUROVIROLOGY, vol. 22, pp. S76 - S77, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394093700158&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Brew BJ; Robertson K; Wright EJ; Churchill M; Crowe SM; Cysique LA; Deeks S; Garcia JV; Gelman B; Gray LR; Johnson T; Joseph J; Margolis DM; Mankowski JL; Spencer B, 2015, 'HIV eradication symposium: will the brain be left behind?', Journal of NeuroVirology, vol. 21, pp. 322 - 334, http://dx.doi.org/10.1007/s13365-015-0322-6
2015
Britton PN; Eastwood K; Brew BJ; Nagree Y; Jones CA, 2015, 'Consensus guidelines for the investigation and management of encephalitis', Medical Journal of Australia, vol. 202, pp. 576 - 577, http://dx.doi.org/10.5694/mja14.01042
2015
Inder KJ; Hussain R; Allen J; Brew B; Lewin TJ; Attia J; Kelly BJ, 2015, 'Factors associated with personal hopefulness in older rural and urban residents of New South Wales', Advances in Mental Health, vol. 13, pp. 43 - 57, http://dx.doi.org/10.1080/18374905.2015.1039186
2015
Jones SP; Franco NF; Varney B; Sundaram G; Brown DA; De Bie J; Lim CK; Guillemin GJ; Brew BJ, 2015, 'Expression of the kynurenine pathway in human peripheral blood mononuclear cells: Implications for inflammatory and neurodegenerative disease', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0131389
2015
Britton PN; Eastwood K; Paterson B; Durrheim DN; Dale RC; Cheng AC; Kenedi C; Brew BJ; Burrow J; Nagree Y; Leman P; Smith DW; Read K; Booy R; Jones CA, 2015, 'Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand', Internal Medicine Journal, vol. 45, pp. 563 - 576, http://dx.doi.org/10.1111/imj.12749
2015
Wright EJ; Grund B; Cysique LA; Robertson KR; Brew BJ; Collins G; Shlay JC; Winston A; Read TRH; Price RW, 2015, 'Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial', HIV MEDICINE, vol. 16, pp. 97 - 108, http://dx.doi.org/10.1111/hiv.12238
2015
Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CSN; Davies NNWS; Price P; Brew BJ, 2015, 'APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - A cross-sectional observational study', BMC Neurology, vol. 15, http://dx.doi.org/10.1186/s12883-015-0298-0
2015
Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2015, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults', Journal of NeuroVirology, vol. 22, pp. 56 - 65, http://dx.doi.org/10.1007/s13365-015-0368-5
2015
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies JM; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2015, 'A new era in the treatment of multiple sclerosis', Medical Journal of Australia, vol. 203, pp. 139 - 141, http://dx.doi.org/10.5694/mja14.01218
2015
Cysique LA; Hey-Cunningham WJ; Dermody N; Chan P; Brew BJ; Koelsch KK, 2015, 'Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0120488
2015
Lundgren J; Babiker A; Gordin F; Emery S; Fätkenheuer G; Molina JM; Wood R; Neaton JD; Agan BK; Alston-Smith B; Arenas-Pinto A; Arribas JR; Baker JV; Baxter J; Belloso WH; Brekke K; Brew B; Brobst SW; Burman W; Carey C; Clark R; Cooper DA; Davey RT; De La Rosa G; Denning ET; Dolan M; Dore G; Duprez D; Emanuel E; Grady C; Grund B; Hirschel B; Hoen B; Hudson F; Johnson MA; Kambili C; Klingman K; Kunisaki KM; Landay A; Ledergerber B; Lehrman SN; Martinez A; Meger S; Misar K; Mitsuyasu RT; Mocroft A; Munroe D; Norton M; Palmer RC; Pett SL; Phillips A; Pillay D; Porter D; Price RW; Proschan M; Rappoport C; Reiss P; Renjifo B; Robertson K; Rockstroh J; Rodriguez G; Rooney JF; Ross MJ; Schechter M; Schwarze S; Seekins D; Sharma S; Snowden W; Telenti A; Tryon J; van Wyk J; Vjecha MJ; Wright E, 2015, 'Why START? Reflections that led to the conduct of this large long-term strategic HIV trial', HIV Medicine, vol. 16, pp. 1 - 9, http://dx.doi.org/10.1111/hiv.12227
2015
Watts J; Brew B; Tisch S, 2015, 'Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria', Journal of Clinical Neuroscience, vol. 22, pp. 1979 - 1981, http://dx.doi.org/10.1016/j.jocn.2015.05.032
2015
Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ, 2015, 'Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab', Journal of Clinical Neuroscience, vol. 22, pp. 598 - 600, http://dx.doi.org/10.1016/j.jocn.2014.08.016
2015
Fois AF; Brew BJ, 2015, 'The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication', Current HIV/AIDS Reports, vol. 12, pp. 299 - 303, http://dx.doi.org/10.1007/s11904-015-0257-9
2015
Dwyer R; Wenhui L; Cysique L; Brew BJ; Lal L; Bain P; Wesselingh S; Wright EJ, 2014, 'Symptoms of depression and rates of neurocognitive impairment in HIV positive patients in Beijing, China', Journal of Affective Disorders, vol. 162, pp. 89 - 95, http://dx.doi.org/10.1016/j.jad.2014.03.038
2014
Cysique LA; Brew BJ, 2014, 'The effects of HIV and aging on brain functions: Proposing a research framework and update on last 3 years' findings', Current Opinion in HIV and AIDS, vol. 9, pp. 355 - 364, http://dx.doi.org/10.1097/COH.0000000000000078
2014
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ, 2014, 'Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology', PLOS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0112945
2014
Power C; Brew BJ, 2014, 'HIV-1 infection and the nervous system-a shifting target.', Current Opinion in HIV and AIDS, vol. 9, pp. 515 - 516, http://dx.doi.org/10.1097/COH.0000000000000113
2014
Sundaram G; Brew BJ; Jones SP; Adams S; Lim CK; Guillemin GJ, 2014, 'Quinolinic acid toxicity on oligodendroglial cells: Relevance for multiple sclerosis and therapeutic strategies', Journal of Neuroinflammation, vol. 11, http://dx.doi.org/10.1186/s12974-014-0204-5
2014
Brew BJ; Chan P, 2014, 'Update on HIV dementia and HIV-associated neurocognitive disorders', Current Neurology and Neuroscience Reports, vol. 14, http://dx.doi.org/10.1007/s11910-014-0468-2
2014
Chan P; Brew BJ, 2014, 'HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment', Current HIV/AIDS reports, vol. 11, pp. 317 - 324, http://dx.doi.org/10.1007/s11904-014-0221-0
2014
Cysique LA; Heaton RK; Kamminga J; Lane T; Gates TM; Moore DM; Hubner E; Carr A; Brew BJ, 2014, 'HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research', Journal of NeuroVirology, vol. 20, pp. 258 - 268, http://dx.doi.org/10.1007/s13365-014-0242-x
2014
Braidy N; Brew BJ; Inestrosa NC; Chung R; Sachdev P; Guillemin GJ, 2014, 'Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons', Metabolic brain disease, vol. 29, pp. 873 - 883, http://dx.doi.org/10.1007/s11011-014-9557-9
2014
Chan P; Brew BJ, 2014, 'HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment', Current HIV/AIDS reports, vol. 11, pp. 317 - 324, http://dx.doi.org/10.1007/s11904-014-0221-0
2014
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations', Journal of Clinical Neuroscience, vol. 21, pp. 1857 - 1865, http://dx.doi.org/10.1016/j.jocn.2014.01.017
2014
Lu GM; Brew BJ; Siefried KJ; Draper B; Cysique LA, 2014, 'Is the HIV dementia scale a reliable tool for assessing HIV-relatedneurocognitive decline?', Journal of AIDS and Clinical Research, vol. 5, http://dx.doi.org/10.4172/2155-6113.1000269
2014
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies', Journal of Clinical Neuroscience, vol. 21, pp. 1835 - 1846, http://dx.doi.org/10.1016/j.jocn.2014.01.016
2014
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy', Journal of Clinical Neuroscience, vol. 21, pp. 1847 - 1856, http://dx.doi.org/10.1016/j.jocn.2014.01.018
2014
Antinori A; Arendt G; Grant I; Letendre S; Muñoz-Moreno JA; Eggers C; Brew B; Brouillette MJ; Bernal-Cano F; Carvalhal A; Christo PP; Cinque P; Cysique L; Ellis R; Everall I; Gasnault J; Husstedt I; Korten V; Machala L; Obermann M; Ouakinin S; Podzamczer D; Portegies P; Rackstraw S; Rourke S; Sherr L; Streinu-Cercel A; Winston A; Wojna V; Yazdanpannah Y; Arbess G; Baril JG; Begovac J; Bergin C; Bonfanti P; Bonora S; Brinkman K; Canestri A; Cholewinska-Szymanska G; Chowers M; Cooney J; Corti M; Doherty C; Elbirt D; Esser S; Florence E; Force G; Gill J; Goffard JC; Harrer T; Li P; Van De Kerckhove L; Knecht G; Matsushita S; Matulionyte R; McConkey S; Mouglignier A; Oka S; Penalva A; Riesenberg K; Sambatakou H; Tozzi V; Vassallo M; Wetterberg P; Drapato AW, 2013, 'Assessment, diagnosisand treatment of Human Immunodeficiency Virus (HIV)-associated neurocognitive disorders (HAND): A consensus report of the mind exchange program', Clinical Infectious Diseases, vol. 56, pp. 1004 - 1017, http://dx.doi.org/10.1093/cid/cis975
2013
Brown S; Simpson DM; Moyle G; Brew BJ; Schifitto G; Larbalestier N; Orkin C; Fisher M; Vanhove GF; Tobias JK, 2013, 'NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: Integrated analysis of two phase III, randomized, controlled trials', AIDS Research and Therapy, vol. 10, http://dx.doi.org/10.1186/1742-6405-10-5
2013
Clifford DB; Nath A; Cinque P; Brew BJ; Zivadinov R; Gorelik L; Zhao Z; Duda P, 2013, 'A study of mefloquine treatment for progressive multifocal leukoencephalopathy: Results and exploration of predictors of PML outcomes', Journal of NeuroVirology, vol. 19, pp. 351 - 358, http://dx.doi.org/10.1007/s13365-013-0173-y
2013
Braidy N; Lim CK; Guillemin GJ; Grant R; Brew BJ, 2013, 'Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis', Brain Research, http://dx.doi.org/10.1016/j.brainres.2013.08.025
2013
Peluso MJ; Meyerhoff DJ; Price RW; Peterson J; Lee E; Young AC; Walter R; Fuchs D; Brew BJ; Cinque P; Robertson K; Hagberg L; Zetterberg H; Gisslén M; Spudich S, 2013, 'Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection', Journal of Infectious Diseases, vol. 207, pp. 1703 - 1712, http://dx.doi.org/10.1093/infdis/jit088
2013
Crossley KM; Brew BJ, 2013, 'Neurological complications in controlled HIV infection', Current Infectious Disease Reports, vol. 15, pp. 564 - 568, http://dx.doi.org/10.1007/s11908-013-0375-8
2013
Braidy N; Lim CK; Grant R; Brew BJ; Guillemin GJ, 2013, 'Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis', Brain Research, vol. 1537, pp. 267 - 272, http://dx.doi.org/10.1016/j.brainres.2013.08.025
2013
Brew BJ; Gray L; Lewin S; Churchill M, 2013, 'Is specific HIV eradication from the brain possible or needed?', Expert Opinion on Biological Therapy, vol. 13, pp. 403 - 409, http://dx.doi.org/10.1517/14712598.2013.748029
2013
Grund B; Wright EJ; Brew BJ; Price RW; Roediger MP; Bain MP; Hoy JF; Shlay JC; Vjecha MJ; Robertson KR, 2013, 'Improved neurocognitive test performance in both arms of the SMART study: Impact of practice effect', Journal of NeuroVirology, vol. 19, pp. 383 - 392, http://dx.doi.org/10.1007/s13365-013-0190-x
2013
2013, 'The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0062196
2013
Sasson SC; Oon A; Chagantri J; Brew BJ; Carr A, 2013, 'Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report', BMC Infectious Diseases, vol. 13, pp. 396 - 396, http://dx.doi.org/10.1186/1471-2334-13-396
2013
Kamminga J; Cysique LA; Lu G; Batchelor J; Brew BJ, 2013, 'Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide', Current HIV/AIDS Reports, vol. 10, pp. 342 - 355, http://dx.doi.org/10.1007/s11904-013-0176-6
2013
Joseph J; Achim CL; Boivin MJ; Brew BJ; Clifford DB; Colosi DA; Ellis RJ; Heaton RK; Gallo-Diop A; Grant I; Kanmogne GD; Kumar M; Letendre S; Marcotte TD; Nath A; Pardo CA; Paul RH; Pulliam L; Robertson K; Royal W; Sacktor N; Sithinamsuwan P; Smith DM; Valcour V; Wigdahl B; Wood C, 2013, 'Global NeuroAIDS roundtable', Journal of NeuroVirology, vol. 19, pp. 1 - 9, http://dx.doi.org/10.1007/s13365-012-0143-9
2013
LeWitt PA; Boroojerdi B; Surmann E; Poewe W, 2013, 'Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER', JOURNAL OF NEURAL TRANSMISSION, vol. 120, pp. 1069 - 1081, http://dx.doi.org/10.1007/s00702-012-0925-5
2013
Mora-Peris B; MacKie NE; Suan D; Cooper DA; Brew BJ; Winston A, 2013, 'Raltegravir resistance in the cerebrospinal fluid', Infection, vol. 41, pp. 731 - 734, http://dx.doi.org/10.1007/s15010-013-0409-z
2013
Brew BJ; McLean CA; Major EO, 2013, 'Progressive multifocal leukoencephalopathy caused by BK virus?', Medical Journal of Australia, vol. 198, pp. 179 - 180, http://dx.doi.org/10.5694/mja12.11798
2013
Jones SP; Guillemin GJ; Brew BJ, 2013, 'The kynurenine pathway in stem cell biology', International Journal of Tryptophan Research, vol. 6, pp. 57 - 66, http://dx.doi.org/10.4137/IJTR.S12626
2013
Wu W; Nicolazzo JA; Wen L; Chung RS; Stankovic RK; Bao SS; Lim CKE; Brew BJ; Cullen KM; Guillemin GJ, 2013, 'Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain', PLoS One, vol. 8, pp. Article numbere59749, http://dx.doi.org/10.1371/journal.pone.0059749
2013
Chew C; Cysique L; Brew B; Price P, 2012, 'Relationships between genetic markers of neuroinflammation, neurodegeneration and neurocognitive impairment in controlled HIV infection', JOURNAL OF NEUROVIROLOGY, vol. 18, pp. 23 - 24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Adams S; Braidy N; Bessede A; Brew BJ; Grant R; Teo C; Guillemin GJ, 2012, 'Correction: The kynurenine pathway in brain tumor pathogenesis (Cancer Research (2012) 72, (5649-5657))', Cancer Research, vol. 72, pp. 6524, http://dx.doi.org/10.1158/0008-5472.CAN-12-4230
2012
Peluso M; Price R; Peterson J; Lee E; Fuchs D; Brew B; Cinque P; Hagberg L; Zetterberg H; Gisslen M; Spudich S, 2012, 'Primary HIV-1 infection is characterized by elevation of cerebrospinal fluid biomarkers indicating early neuronal damage', JOURNAL OF NEUROVIROLOGY, vol. 18, pp. 83 - 84, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Clifford D; Simpson D; Brown S; Moyle G; Brew BJ; Conway B; Tobias J; Vanhove J, 2012, 'A Randomized, Double-Blind, Controlled Study of NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-Associated Distal Sensory Polyneuropathy', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 59, pp. 126 - 133, http://dx.doi.org/10.1097/QAI.0b013e31823e31f7
2012
Lane TA; Batchelor J; Brew BJ; Cysique LA, 2012, 'Facial emotional processing in HIV infection: relation to neurocognitive and neuropsychiatric status', Neuropsychology, vol. 26, pp. 713 - 722, http://dx.doi.org/10.1037/a0029964
2012
Kandanearatchi ; Brew BJ, 2012, 'The kynurenine pathway and quinolinic acid: Pivotal roles in HIV associated neurocognitive disorders', FEBS Journal, vol. 279, pp. 1366 - 1374, http://dx.doi.org/10.1111/j.1742-4658.2012.08500.x
2012
Cruse B; Cysique LA; Markus R; Brew BJ, 2012, 'Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy', Journal of Neurovirology, vol. 18, pp. 264 - 276, http://dx.doi.org/10.1007/s13365-012-0092-3
2012
Gray L; Tachedjian G; Ellett A; Roche M; Brew B; Turville S; Wesselingh S; Gorry P; Churchill M, 2012, 'Reduced Effectiveness of the NRTIs d4T and AZT in Astrocytes: Implications for Neuro-cART', JOURNAL OF NEUROVIROLOGY, vol. 18, pp. 42 - 43, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Mothobi NZ; Brew BJ, 2012, 'Neurocognitive dysfunction in the highly active antiretroviral therapy era', Current Opinion in Infectious Diseases, vol. 25, pp. 4 - 9, http://dx.doi.org/10.1097/QCO.0b013e32834ef586
2012
Brew BJ; Thompson J, 2012, 'Epilepsy: Issues with antiepileptic drug use in HIV-infected patients', Nature Reviews Neurology, vol. 8, pp. 187 - 188, http://dx.doi.org/10.1038/nrneurol.2012.36
2012
Lim CK; Yap MMC; Kent SJ; Gras G; Samah B; Batten JC; De Rose R; Heng B; Brew BJ; Guillemin GJ, 2012, 'Characterization of the Kynurenine pathway and quinolinic acid production in macaque macrophages', International Journal of Tryptophan Research, vol. 6, pp. 7 - 19, http://dx.doi.org/10.4137/IJTR.S11789
2012
Blair N; Brew BJ; Halpern J, 2012, 'Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance', Neurology, vol. 78, pp. 507 - 508, http://dx.doi.org/10.1212/WNL.0b013e318246d6d8
2012
Cysique L; Brew B, 2012, 'Characteristics of neurocognitive decline in virally-suppressed middle-aged HIV plus individuals', JOURNAL OF NEUROVIROLOGY, vol. 18, pp. 26 - 26, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Adams S; Braidy N; Bess A; Brew BJ; Grant RS; Teo C; Guillemin GJ, 2012, 'The kynurenine pathway in brain tumor pathogenesis', Cancer research, vol. 72, pp. 5649 - 5657, http://dx.doi.org/10.1158/0008-5472.CAN-12-0549
2012
Botes LP; Jin F; Bourne CP; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews G; Brew BJ; Hillman R, 2011, 'Participants' perspectives of self-collected anal cytological swabs', Sexual Health, vol. 8, pp. 257 - 258, http://dx.doi.org/10.1071/SH10037
2011
Maruszak H; Brew BJ; Giovannoni G; Gold J, 2011, 'Could antiretroviral drugs be effective in multiple sclerosis? A case report', European Journal of Neurology, vol. 18, http://dx.doi.org/10.1111/j.1468-1331.2011.03430.x
2011
Croitoru-Lamoury J; Lamoury F; Caristo M; Suzuki K; Walker DW; Takikawa O; Taylor R; Brew BJ, 2011, 'Interferon-c Regulates the Proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO)', PLoS One, vol. 6, pp. 1 - 13, http://dx.doi.org/10.1371/journal.pone.0014698
2011
Cysique LA; Bain MP; Brew BJ; Murray JM, 2011, 'The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future', Sexual Health, vol. 8, pp. 541 - 550, http://dx.doi.org/10.1071/SH11003
2011
Rahman A; Brew BJ; Guillemin GJ, 2011, 'Lead dysregulates serine/threonine protein phosphatases in human neurons', Neurochemical Research, vol. 36, pp. 195 - 204, http://dx.doi.org/10.1007/s11064-010-0300-6
2011
Ng K; Kumar KR; Brew BJ; Burke D, 2011, 'Axonal excitability in viral polyneuropathy and nucleoside neuropathy in HIV patients', Journal of Neurology Neurosurgery and Psychiatry, vol. 82, pp. 978 - 980, http://dx.doi.org/10.1136/jnnp.2009.203091
2011
Tippett M; Cheng W; Westhorpe R; Cameron A; Brew BJ; Lewin S; Jaworowski A; Crowe S, 2011, 'Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals', PLoS One, vol. 6, pp. 1 - 11, http://dx.doi.org/10.1371/journal.pone.0019968
2011
Wright E; Grund B; Robertson K; Brew B; Price R, 2011, 'CARDIOVASCULAR RISK FACTORS ASSOCIATED WITH LOWER BASELINE COGNITIVE PERFORMANCE IN HIV-POSITIVE PERSONS Reply', NEUROLOGY, vol. 77, pp. 407 - 407, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000293123300026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Chen Y; Brew BJ; Guillemin GJ, 2011, 'Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis', Journal of Neurochemistry, vol. 118, pp. 816 - 825, http://dx.doi.org/10.1111/j.1471-4159.2010.07159.x/abstract;jsessionid=83A44016D40A402F78AD97483FD7AAFE.d02t04?systemMessage=Wiley+Online+Library+will+be+disrupted+14+May+from+10-12+BST+for+monthly+maintenance
2011
Hillman R; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews GV; Brew BJ; Milliken S; Botes LP, 2011, 'Participants' perspectives of high resolution anoscopy', Sexual Health, vol. 8, pp. 255 - 256, http://dx.doi.org/10.1071/SH10116
2011
Spudich S; Gisslen M; Hagberg L; Lee E; Liegler T; Brew BJ; Fuchs A; Tambussi G; Cinque P; Hecht FM; Price R, 2011, 'Central nervous system immune activation characterizes primary HIV-1 infection even in subjects with minimal cerebrospinal fluid viral burden', Journal of Infectious Diseases, vol. 204, pp. 753 - 760, http://dx.doi.org/10.1093/infdis/jir387
2011
McManus H; Lim P; Nolan D; Bloch M; Kiertiburanakul S; Choi J; Mulhall BP; Petoumenos K; Zhou J; Law MG; Brew BJ; Wright E, 2011, 'Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?', HIV Medicine, vol. 12, pp. 610 - 619, http://dx.doi.org/10.1111/j.1468-1293.2011.00938.x
2011
Maher A; Cysique LA; Brew BJ; Rae CD, 2011, 'Statistical integration of 1H NMR and MRS data from difefrent biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection', Journal of Proteome Research, vol. 10, pp. 1737 - 1745, http://dx.doi.org/10.1021/pr1010263
2011
Cysique LA; Waters EK; Brew BJ, 2011, 'Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research', BMC NEUROLOGY, vol. 11, pp. 148 - 158, http://dx.doi.org/10.1186/1471-2377-11-148
2011
Wright E; Grund B; Robertson K; Brew B; Price R, 2011, 'Reply from the authors', Neurology, vol. 77, pp. 407, http://dx.doi.org/10.1212/WNL.0b013e3182246fb2
2011
Maruszak A; Brew BJ; Giovannoni G; Gold J, 2011, 'Could antiretroviral drugs be effective in multiple sclerosis? A case report', European Journal of Neurology, vol. 18, pp. 110 - 111, http://dx.doi.org/10.1111/j.1468-1331.2011.03430.x/pdf
2011
Lim CK; Brew BJ; Sundaram G; Guillemin GJ, 2010, 'Understanding the roles of the kynurenine pathway in multiple sclerosis progression', International Journal of Tryptophan Research, vol. 3, pp. 157 - 167
2010
Davies NWS; Guillemin G; Brew BJ, 2010, 'Tryptophan, neurodegeneration and HIV-associated neurocognitive disorder', International Journal of Tryptophan Research, vol. 3, pp. 121 - 140
2010
Lifson A; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Krum E; Nelson R; Pedersen C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J, 2010, 'Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials', HIV Clinical Trials, vol. 11, pp. 205 - 219, http://dx.doi.org/10.1310/hct1104-205
2010
Brew BJ, 2010, 'HIV and the Acquired Immunodeficiency Syndrome: An Overview of Neurological Complications', International Neurology: A Clinical Approach, pp. 340 - 341, http://dx.doi.org/10.1002/9781444317008.ch92
2010
Tisch S; Brew BJ, 2010, 'HIV, HAART, and parkinson's disease: Co-incidence or pathogenetic link?', Movement Disorders, vol. 25, pp. 2257 - 2258, http://dx.doi.org/10.1002/mds.23277
2010
Cherry CL; Affandi JS; Brew BJ; Creighton J; Djauzi S; Hooker DJ; Imran D; Kamarulzaman A; Kamerman P; McArthur JC; Moore RD; Price P; Smyth K; Tan IL; Vanar S; Wadley A; Wesselingh SL; Yunihastuti E, 2010, 'Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV', Neurology, vol. 74, pp. 1538 - 1542, http://dx.doi.org/10.1212/WNL.0b013e3181dd436d
2010
Zhou L; Diefenbach E; Crossett B; Tran SL; Ng T; Rizos H; Rua R; Wang B; Kapur A; Gandhi K; Brew BJ; Saksena NK, 2010, 'First evidence of overlaps between HIV-associated dementia (HAD) and non-viral neurodegenerative diseases: Proteomic analysis of the frontal cortex from HIV+ patients with and without dementia', Molecular Neurodegeneration, vol. 5, http://dx.doi.org/10.1186/1750-1326-5-27
2010
Brew BJ; Cysique LA, 2010, 'Editorial: Alzheimer disease and HIV: A tangled story', Neurology, vol. 75, pp. 105 - 106, http://dx.doi.org/10.1212/WNL.0b013e3181e7b6a4
2010
Hagberg L; Cinque P; Gisslen M; Brew BJ; Spudich S; Bestetti A; Price RW; Fuchs D, 2010, 'Cerebrospinal fluid neopterin: An informative biomarker of central nervous system immune activation in HIV-1 infection', AIDS Research and Therapy, vol. 7, http://dx.doi.org/10.1186/1742-6405-7-15
2010
Lee M; Ting KK; Adams S; Brew BJ; Chung R; Guillemin GJ, 2010, 'Characterisation of the expression of NMDA receptors in human astrocytes', PLoS One, vol. 5, pp. e14123, http://dx.doi.org/10.1371/journal.pone.0014123
2010
McArthur JC; Brew BJ, 2010, 'HIV-associated neurocognitive disorders: Is there a hidden epidemic?', AIDS, vol. 24, pp. 1367 - 1370, http://dx.doi.org/10.1097/QAD.0b013e3283391d56
2010
Brew BJ, 2010, 'HIV-Associated Cerebral Opportunistic Infections', International Neurology: A Clinical Approach, pp. 356 - 359, http://dx.doi.org/10.1002/9781444317008.ch97
2010
Brew BJ; Davies NWS; Cinque P; Clifford D; Nath A, 2010, 'Progressive multifocal leukoencephalopathy and other forms of JC virus disease', Nature Reviews Neuroscience, vol. 6, pp. 667 - 679, http://dx.doi.org/10.1038/nrneurol.2010.164
2010
Brew BJ, 2010, 'HIV-Associated Lymphoma: Neurologic Complications', International Neurology: A Clinical Approach, pp. 360 - 361, http://dx.doi.org/10.1002/9781444317008.ch98
2010
Brew BJ, 2010, 'Neurodegeneration in the HAART era', RETROVIROLOGY, vol. 7, pp. 3 - 3, http://dx.doi.org/10.1186/1742-4690-7-S1-I7
2010
Brew BJ, 2010, 'Benefit or toxicity from neurologically targeted antiretroviral therapy?', Clinical Infectious Diseases, vol. 50, pp. 930 - 932, http://dx.doi.org/10.1086/650744
2010
Dunbar M; Murray JM; Cysique LA; Brew BJ; Jeyakumar V, 2010, 'Simultaneous classification and feature selection via convex quadratic programming with application to HIV-associated neurocognitive disorder assessment', European Journal of Operational Research, vol. 206, pp. 470 - 478, http://dx.doi.org/10.1016/j.ejor.2010.03.017
2010
Guillemin GJ; Rahman A; Ting K; Cullen KM; Braidy N; Chung RS; Wu W; Brew BJ, 2010, 'INVOLVEMENT OF THE KYNURENINE PATHWAY IN ALZHEIMER'S DISEASE', JOURNAL OF NEUROCHEMISTRY, vol. 115, pp. 39 - 39, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281812600096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sheffief S; Wang B; Saksena N; Purcell DFJ; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR, 2009, 'Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain', Journal of Virology, vol. 83, pp. 5430 - 5441, http://dx.doi.org/10.1128/JVI.02648-08
2009
Brew BJ, 2009, 'HIV, the brain, children, HAART and `neuro-HAART`: A complex mix', AIDS, vol. 23, pp. 1909 - 1910, http://dx.doi.org/10.1097/QAD.0b013e32832ec4c6
2009
Braidy N; Grant RS; Brew BJ; Adams S; Jayasena T; Guillemin GJ, 2009, 'Effects of Kynurenine Pathway Metabolites on Intracellular NAD+ Synthesis and Cell Death in Human Primary Astrocytes and Neurons', International Journal of Tryptophan Research : IJTR, vol. 2, pp. 61 - 69
2009
Joseph J; Clifford D; Douglas SD; Fox H; Gendelman HE; Gonzalez-Scarano F; Grant I; Major E; McArthur J, 2009, 'Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008', JOURNAL OF NEUROIMMUNE PHARMACOLOGY, vol. 4, pp. 283 - 297, http://dx.doi.org/10.1007/s11481-009-9159-1
2009
Sher L; Cramer D; Grinyer J; Hall BM; Brayman K; Mirmira R, 2009, 'Editorial introductions', Current Opinion in Organ Transplantation, vol. 14
2009
Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherieff S; Wang B; Saksena N; Purcell DFJ; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR, 2009, 'Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain (Journal of Virology (2009) 83, 11, (5430-5441))', Journal of Virology, vol. 83, pp. 7794, http://dx.doi.org/10.1128/JVI.01082-09
2009
Brew BJ; Crowe S; Landay A; Cysique LA; Guillemin GJ, 2009, 'Neurodegeneration and ageing in the HAART era', JOURNAL OF NEUROIMMUNE PHARMACOLOGY, vol. 4, pp. 163 - 174, http://dx.doi.org/10.1007/s11481-008-9143-1
2009
Churchill MJ; Wesselingh SL; Cowley D; Pardo CA; McArthur JC; Brew BJ; Gorry PR, 2009, 'Extensive astrocyte infection is prominent in human immunodeficiency virus - associated dementia', Annals of Neurology, vol. 66, pp. 253 - 258, http://dx.doi.org/10.1002/ana.21697
2009
Ting KK; Brew BJ; Guillemin GJ, 2009, 'Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease', Journal of Neuroinflammation, vol. 6, pp. 1 - 13, http://dx.doi.org/10.1186/1742-2094-6-36
2009
Cysique LA; Brew BJ, 2009, 'Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: A review', Neuropsychology Review, vol. 19, pp. 169 - 185, http://dx.doi.org/10.1007/s11065-009-9092-3
2009
Tisch S; Brew BJ, 2009, 'Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', Neurology, vol. 73, pp. 401 - 403, http://dx.doi.org/10.1212/WNL.0b013e3181b04b0d
2009
Gisslén M; Krut J; Andreasson U; Blennow K; Cinque P; Brew BJ; Spudich S; Hagberg L; Rosengren L; Price RW; Zetterberg H, 2009, 'Amyloid and tau cerebrospinal fluid biomarkers in HIV infection', BMC Neurology, vol. 9, http://dx.doi.org/10.1186/1471-2377-9-63
2009
Braidy N; Grant RS; Adams S; Brew BJ; Guillemin GJ, 2009, 'Mechanism for quinolinic acid cytotoxicity in human astrocytes & neurons', Neurotoxicity Research, vol. 16, pp. 77 - 86, http://dx.doi.org/10.1007/s12640-009-9051-z
2009
Tan IL; Brew BJ, 2009, 'Possible JCV granular cell neuronopathy in a patient with HIV infection', Neurology, vol. 73, pp. 1598 - 1599, http://dx.doi.org/10.1212/WNL.0b013e3181c0d6cb
2009
Maruff P; Thomas E; Cysique LA; Brew BJ; Collie A; Snyder P; Pietrzak R, 2009, 'Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex', Archives of Clinical Neuropsychology, vol. 24, pp. 165 - 178, http://dx.doi.org/10.1093/arclin/acp010
2009
Rahman A; Ting K; Cullen KM; Braidy N; Brew BJ; Guillemin GJ, 2009, 'The excitotoxin quinolinic acid induces tau phosphorylation in human neurons', PLoS One, vol. 4, pp. e6344 -1 - 15, http://dx.doi.org/10.1371/journal.pone.0006344
2009
Cherry C; Duncan A; Mackie K; Wesselingh S; Brew BJ, 2008, 'A Report on the Effect of Commencing Enfuvirtide on Peripheral Neuropathy', AIDS Research and Human Retroviruses, vol. 24, pp. 1027 - 1030, http://dx.doi.org/10.1089/aid.2007.0300
2008
Owe-Young R; Webster N; Mukhtar M; Pomerantz R; Smythe GA; Walker DW; Armati P; Crowe SM; Brew BJ, 2008, 'Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance & neurotoxicity', Journal of Neurochemistry, vol. 105, pp. 1346 - 1357, http://dx.doi.org/10.1111/j.1471-4159.2008.05241.x
2008
Maneglier B; Guillemin GJ; Clayette P; Rogez-Kreuz C; Brew BJ; Dormont D; Advenier C; Therond P; Spreux-Varoquaux O, 2008, 'Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT1A receptors', British Journal of Pharmacology, vol. 154, pp. 174 - 182, http://dx.doi.org/10.1038/bjp.2008.80
2008
Maneglier B; Guillemin G; Clayette P; Brew B; Rogez-Kreuz C; Advenier C; Spreux-Varoquaux O, 2008, 'Involvement of tryptophan catabolism during HIV-1 infection in primary culture of human monocytes-derived macrophages', FUNDAMENTAL & CLINICAL PHARMACOLOGY, vol. 22, pp. 99 - 99, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256760500481&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2008
Brew BJ; Letendre S, 2008, 'Biomarkers of HIV related central nervous system disease', International Review of Psychiatry, vol. 20, pp. 73 - 88, http://dx.doi.org/10.1080/09540260701878082
2008
Batmanian JJ; Lam M; Matthews C; Finckh A; Duffy M; Wright R; Brew BJ; Markus R, 2008, 'Reply', Medical Journal of Australia, vol. 188, pp. 489 - 490
2008
Batmanian JJ; Lam M; Matthews C; Finckh AS; Duffy MT; Wright RO; Brew BJ; Markus R, 2008, 'Tissue plasminogen activator for acute ischaemic stroke - Reply', Medical Journal of Australia, vol. 188, pp. 489 - 490, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256113000019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2008
Wright E; Brew BJ; Lal L; Ali ST; Arayawichanont A; Imran D; Kamarulzaman A; Kongsaengdao S; Kruy L; Merati T; Samintharapanya K; Sarim C; Tau G; Thangsing C; Vin-Samnang C; Wesselingh S, 2008, 'Response to Birbeck et al', Epilepsia, vol. 49, pp. 541 - 543, http://dx.doi.org/10.1111/j.1528-1167.2007.01529_5.x
2008
Wright E; Brew BJ; Wesselingh S, 2008, 'Pathogenesis and diagnosis of viral infections of the nervous system', Neurologic Clinics, vol. 26, pp. 617 - 617, http://dx.doi.org/10.1016/j.ncl.2008.03.006
2008
Ting KK; Brew BJ; Guillemin GJ, 2008, 'The involvement of astrocytes and kynurenine pathway in Alzheimer`s disease', Neurotoxicity Research, vol. 12, pp. 247 - 262
2008
Wright E; Brew BJ; Arayawichanont A; Robertson K; Samintharapanya K; Kongsaengdao S; Lim M; Vonthanak S; Lal L; Sarim C; Huffam SE; Li P; Imran D; Lewis J; Lun W; Kamarulzaman A; Tau G; Ali ST; Kishore K; Bain MA; Dwyer R; McCormack G; Hellard M; Cherry C; McArthur J; Wesselingh S, 2008, 'Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region', Neurology, vol. 71, pp. 50 - 56, http://dx.doi.org/10.1212/01.wnl.0000316390.17248.65
2008
Wright E; Nunn M; Joseph J; Robertson K; Lal L; Brew BJ, 2008, 'NeuroAIDS in the Asia Pacific Region', Journal of Neurovirology, vol. 14, pp. 465 - 473, http://dx.doi.org/10.1080/13550280802235932
2008
Pemberton LA; Stone E; Price P; van Bockxmeer FM; Brew BJ, 2008, 'The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia', HIV Medicine, vol. 9, pp. 677 - 680, http://dx.doi.org/10.1111/j.1468-1293.2008.00614.x
2008
Lim CK; Smythe GA; Stocker R; Brew BJ; Guillemin GJ, 2007, 'Characterization of the kynurenine pathway in primary human oligodendrocytes', International Congress Series, vol. 1304, pp. 213 - 217, http://dx.doi.org/10.1016/j.ics.2007.07.011
2007
Gisslen M; Hagberg L; Brew BJ; Cinque P; Price R; Rosengren L, 2007, 'Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex', Journal of Infectious Diseases, vol. 195, pp. 1774 - 1778, http://dx.doi.org/10.1086/518043
2007
Croitoru-Lamoury J; Lamoury F; Zaunders J; Veas LA; Brew BJ, 2007, 'Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone', Journal of Interferon and Cytokine Research, vol. 27, pp. 53 - 64, http://dx.doi.org/10.1089/jir.2006.0037
2007
Gisslen M; Hagberg L; Rosengren L; Brew BJ; Cinque P; Spudich S; Price R, 2007, 'Defining and evaluating HIV-Related neurodegenerative disease and its treatment targets: A combinatorial approach to use of cerebrospinal fluid molecular biomarkers', JOURNAL OF NEUROIMMUNE PHARMACOLOGY, vol. 2, pp. 112 - 119, http://dx.doi.org/10.1007/s11481-006-9035-1
2007
Cinque P; Brew BJ; Gisslen M; Hagberg L; Price RW, 2007, 'Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex', Handbook of Clinical Neurology, vol. 85, pp. 261 - 300, http://dx.doi.org/10.1016/S0072-9752(07)85017-2
2007
Ting KK; Brew BJ; Guillemin GJ, 2007, 'Effect of Quinolinic acid on gene expression in human Astrocytes: Implications on Alzheimer’s disease', International Congress Series, vol. 1304, pp. 384 - 388, http://dx.doi.org/10.1016/j.ics.2007.07.010
2007
Ting KK; Brew BJ; Guillemin GJ, 2007, 'The involvement of astrocytes and kynurenine pathway in Alzheimer`s disease', Neurotoxicity Research, vol. 12, pp. 247 - 262, http://dx.doi.org/10.1007/BF03033908
2007
Guillemin GJ; Brew BJ, 2007, 'Chronic HIV infection leads to an Alzheimer’s disease like illness - Involvement of the kynurenine pathway', International Congress Series, vol. 1304, pp. 324 - 334, http://dx.doi.org/10.1016/j.ics.2007.07.031
2007
Thein H; Maruff P; Krahn M; Kaldor JM; Koorey D; Brew BJ; Dore GJ, 2007, 'Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment', HIV Medicine, vol. 8, pp. 192 - 202, http://dx.doi.org/10.1111/j.1468-1293.2007.00452.x
2007
Brew BJ, 2007, 'HAD and the need for new trial design methodology', AIDS, vol. 21, pp. 1965 - 1966, http://dx.doi.org/10.1097/QAD.0b013e328133850e
2007
Drake A; Loy CT; Brew BJ; Chen TP; Petoumenos K; Li P; Wright E, 2007, 'Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival', European Journal of Neurology, vol. 14, pp. 418 - 423, http://dx.doi.org/10.1111/j.1468-1331.2007.01686.x
2007
Brew BJ; Gonzalez-Scarano F, 2007, 'Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa [7]', Neurology, vol. 69, pp. 412 - 413, http://dx.doi.org/10.1212/01.wnl.0000278073.28318.66
2007
Brew BJ, 2007, 'Neurological sequelae of primary HIV infection', Handbook of Clinical Neurology, vol. 85, pp. 69 - 77, http://dx.doi.org/10.1016/S0072-9752(07)85005-6
2007
Guillemin GJ; Cullen K; Smythe GA; Kapoor V; Lim E; Garner B; Takikawa O; Brew BJ, 2007, 'Characterization of the kynurenine pathway in human neurons', Journal of the History of the Neurosciences, vol. 27, pp. 12884 - 12892
2007
Brew BJ; Gonzalez-Scarano F, 2007, 'HIV-associated dementia - An inconvenient truth', Neurology, vol. 68, pp. 324 - 325, http://dx.doi.org/10.1212/01.wnl.0000252803.24176.76
2007
Brew BJ; Gonzalez-Scarano F, 2007, 'Frequency of and risk factors for HIV dementia in an HIV clinic in sub-saharan Africa - Reply from the editorialists', NEUROLOGY, vol. 69, pp. 412 - 413, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000248243300024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2007
Thein H; Maruff P; Krahn M; Kaldor JM; Koorey D; Brew BJ; Dore GJ, 2007, 'Improved cognitive function as a consequence of hepatitis C virus treatment', HIV Medicine, vol. 8, pp. 520 - 528, http://dx.doi.org/10.1111/j.1468-1293.2007.00505.x
2007
Brew BJ, 2007, 'AIDS dementia complex', Handbook of Clinical Neurology, vol. 85, pp. 79 - 91, http://dx.doi.org/10.1016/S0072-9752(07)85006-8
2007
Guillemin GJ; Cullen K; Lim C; Smythe GA; Garner B; Kapoor V; Takikawa O; Brew BJ, 2007, 'Characterization of the kynurenine pathway in human neurons', Journal of Neuroscience, vol. 27, pp. 12884 - 12892, http://dx.doi.org/10.1523/JNEUROSCI.4101-07.2007
2007
Brew BJ; Halman M; Catalan J; Sacktor N; Price R; Brown S; Atkinson H; Clifford D; Simpson D; Torres G; Hall C; Power C; Marder K; Mc Arthur J; Symonds W; Romero C, 2007, 'Factors in AIDS dementia complex trial design: Results and lessons from the abacavir trial', PLoS Clinical Trials, vol. 2, http://dx.doi.org/10.1371/journal.pctr.0020013
2007
Abdulle S; Mellgren A; Brew BJ; Cinque P; Hagberg L; Price R; Rosengren L; Gisslen M, 2007, 'CSF neurofilament protein (NFL) - a marker of active HIV-related neurodegeneration', Journal of Neurology, vol. 254, pp. 1026 - 1032, http://dx.doi.org/10.1007/s00415-006-0481-8
2007
Guillemin GJ; Brew BJ; Noonan C; Knight TG; Cullen K, 2007, 'Mass spectrometric detection of quinolinic acid in microdissected Alzheimer disease plaques', International Congress Series, vol. 1304, pp. 404 - 408, http://dx.doi.org/10.1016/j.ics.2007.07.012
2007
Gorry P; Mcphee D; Verity E; Dyer W; Wesselingh S; Learmont J; Sullivan JS; Roche M; Zaunders J; Gabuzda D; Crowe S; Mills J; Lewin S; Brew BJ; Cunningham AL; Churchill M, 2007, 'Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo', Retrovirology, vol. 4 (66), http://dx.doi.org/10.1186/1742-4690-4-66
2007
Mellgren A; Price R; Hagberg L; Rosengren L; Brew BJ; Gisslen M, 2007, 'Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection', Neurology, vol. 69 (15), pp. 1536 - 1541, http://dx.doi.org/10.1212/01.wnl.0000277635.05973.55
2007
Brew BJ, 2007, 'Lost in translation: Again, another failed neuroprotection trial', Neurology, vol. 69, pp. 1308 - 1309, http://dx.doi.org/10.1212/01.wnl.0000277530.05450.ff
2007
Batmanian JJ; Lam MK; Matthews C; Finckh AS; Duffy MT; Wright RO; Brew BJ; Markus R, 2007, 'A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department', Medical Journal of Australia, vol. 187, pp. 567 - 570
2007
Churchill MJ; Figueiredo A; Cowley D; Gray L; Purcell DFJ; Sullivan JS; McPhee DA; Wesselingh SL; Brew BJ; Gorry PR, 2006, 'Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia', Journal of NeuroVirology, vol. 12, pp. 219 - 228, http://dx.doi.org/10.1080/13550280600827369
2006
Shah M; Smit T; Morgello S; Tourtellotte W; Gelman B; Brew BJ; Saksena N, 2006, 'Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usage', AIDS Research and Human Retroviruses, vol. 22, pp. 177 - 181, http://dx.doi.org/10.1089/aid.2006.22.177
2006
Cysique LA; Maruff P; Brew BJ, 2006, 'Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study', BMC NEUROLOGY, vol. 6, pp. 42 - 42, http://dx.doi.org/10.1186/1471-2377-6-42
2006
Cysique LA; Maruff P; Brew BJ, 2006, 'Variable benefit in neuropsychological function in HIV-infected HAART-treated patients', Neurology, vol. 66, pp. 1447 - 1450, http://dx.doi.org/10.1212/01.wnl.0000210477.63851.d3
2006
Croitoru-Lamoury J; Williams K; Lamoury F; Veas LA; Ajami B; Taylor R; Brew BJ, 2006, 'Neural transplantation of human MSC and NT2 cells in the twitcher mouse model', Cytotherapy, vol. 8, pp. 445 - 458, http://dx.doi.org/10.1080/14653240600879152
2006
Guillemin GJ; Meininger V; Brew BJ, 2006, 'Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis (Review)', Neurodegenerative Diseases, vol. 2, pp. 166 - 176, http://dx.doi.org/10.1159/000089622
2006
Lamoury F; Croitoru-Lamoury J; Brew BJ, 2006, 'Undifferentiated mouse mesenchymal stem cells spontaneously express neural and stem cell markers Oct-4 and Rex-1', Cytotherapy, vol. 8, pp. 228 - 242, http://dx.doi.org/10.1080/14653240600735875
2006
Cysique LA; Maruff P; Brew BJ, 2006, 'The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: A meta-analysis', Journal of the International Neuropsychological Society, vol. 12, pp. 368 - 382, http://dx.doi.org/10.1017/S1355617706060401
2006
Cysique LA; Maruff P; Darby D; Brew BJ, 2006, 'The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery', Archives of Clinical Neuropsychology, vol. 21, pp. 185 - 194, http://dx.doi.org/10.1016/j.acn.2005.07.011
2006
Guillemin GJ; Brew BJ; Noonan C; Takikawa O; Cullen K, 2005, 'Indoleamine 2,3 dioxygenase and quinolinic acid in plaque and neurons in post-mortem brain tissue from Alzheimer`s disease and control cases', Neuropathology and Applied Neurobiology, vol. 31, pp. 395 - 404
2005
Cysique LA; Brew BJ; Halman M; Catalan J; Sacktor N; Price R; Brown S; Atkinson JH; Clifford D; Simpson D; Torres G; Hall C; Power C; Marder K; McArthur J; Symonds W; Romero C, 2005, 'Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 39, pp. 426 - 429, http://dx.doi.org/10.1097/01.qai.0000165799.59322.f5
2005
McArthur J; Brew BJ; Nath A, 2005, 'Neurological complications of HIV infection', Lancet Neurology, vol. 4, pp. 543 - 555, http://dx.doi.org/10.1016/S1474-4422(05)70165-4
2005
Winston A; Marriott D; Brew BJ, 2005, 'Early syphilis presenting as a painful polyradiculopathy in an HIV positive individual', Sexually Transmitted Infections, vol. 81, pp. 133 - 134, http://dx.doi.org/10.1136/sti.2004.011668
2005
Brew BJ; Pemberton LA; Blennow K; Wallin A; Hagberg L, 2005, 'CSF amyloid beta 42 and tau levels correlate with AIDS dementia complex', Neurology, vol. 65, pp. 1490 - 1492, http://dx.doi.org/10.1212/01.wnl.0000183293.95787.b7
2005
Guillemin GJ; Wang L; Brew BJ, 2005, 'Quinolinic acid induces apoptosis of human astrocyte', Journal of Neuroinflammation
2005
2005
Berger J; Brew BJ, 2005, 'An international screening tool for HIV dementia', AIDS, vol. 19, pp. 2165 - 2166, http://dx.doi.org/10.1097/01.aids.0000194798.66670.6e
2005
Crowe S; Ho D; Marriott D; Brew BJ; Gorry P; Sullivan JS; Learmont JC; Mills J, 2005, 'In vivo replication kinetics of a nef-deleted strain of HIV-1', AIDS, vol. 19, pp. 842 - 843, http://dx.doi.org/10.1097/01.aids.0000168984.05209.f1
2005
Guillemin GJ; Smythe GA; Takikawa O; Brew BJ, 2005, 'Expression of indoleamine 2,3 dioxygenase and production of quinolinic acid by human microglia, astrocytes and neurons', Glia, vol. 49, pp. 15 - 23
2005
Lamour Y; Veas LA; Lamoury F; Brew BJ, 2005, 'Human mesenchymal stem cells constitutively express chemokines and chemokine receptors which can be upregulated by cytokines, ifn-beta and copaxone', Journal of the Neurological Sciences, vol. 238, pp. S233 - S233, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088002145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Guillemin GJ; Brew BJ; Noonan CE; Knight TG; Smythe G; Callen KM, 2005, 'Mass spectroscopic detection of quinolinic acid in microdissected Alzheimer's disease plaques', INFLAMMATION RESEARCH, vol. 54, pp. S200 - S200, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000205501600374&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2005
Guillemin GJ; Smythe GA; Takikawa O; Brew BJ, 2005, 'Expression of indoleamine 2,3-dioxygenase and production of quinolinicacid by human microglia, astrocytes, and neurons', Glia, vol. 49, pp. 15 - 23, http://dx.doi.org/10.1002/glia.20090
2005
Guillemin GJ; Cullen KM; Smythe GA; Brew BJ, 2005, 'Involvement of the kynurenine pathway in neuroinflammation', INFLAMMATION RESEARCH, vol. 54, pp. S199 - S199, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000205501600371&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2005
Brew B, 2005, 'Relativity and relativism [9]', New Scientist, vol. 188, pp. 27
2005
Guillemin GJ; Wang L; Brew BJ, 2005, 'Quinolinic acid selectively induces apoptosis of human astocytes: Potential role in AIDS dementia complex', Journal of Neuroinflammation, vol. 2, http://dx.doi.org/10.1186/1742-2094-2-16
2005
Guillemin GJ; Brew BJ; Noonan C; Takikawa O; Cullen K, 2005, 'Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer`s disease hippocampus', Neuropathology and Applied Neurobiology, vol. 31, pp. 395 - 404, http://dx.doi.org/10.1111/j.1365-2990.2005.00655.x
2005
Batmanian J; Brew BJ, 2005, 'Clinical significance of central nervous system as sanctuary site for HIV', Journal of HIV therapy, vol. 10, pp. 16 - 21
2005
Guillemin GJ; Kerr SJ; Brew BJ, 2005, 'Involvement of quinolinic acid in AIDS dementia complex', Neurotoxicity Research, vol. 7, pp. 103 - 123, http://dx.doi.org/10.1007/BF03033781
2005
Brew BJ, 2005, 'HIV and the nervous system - palliative carte aspects', Journal of the Neurological Sciences, vol. 238, pp. S38 - S38, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088000158&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Smit T; Brew BJ; Tourtellotte W; Morgello S; Gelman B; Saksena NK, 2004, 'Independent evolution of human immunodeficiency virus (HIV) drugresistance mutations in diverse areas of the brain in HIV-infectedpatients, with and without dementia, on antiretroviral treatment', Journal of Virology, vol. 78, pp. 10133 - 10148, http://dx.doi.org/10.1128/JVI.78.18.10133-10148.2004
2004
Brew BJ, 2004, 'HAART in AIDS dementia complex and palliative care', Progress in Palliative Care, vol. 12, pp. 171 - 177, http://dx.doi.org/10.1179/096992604225006370
2004
Brew BJ; Tomlinson SE, 2004, 'HIV neuropathy: time for new therapies', Drug Discovery Today-Disease Models, vol. 1, pp. 171 - 176, http://dx.doi.org/10.1016/j.ddmod.2004.09.012
2004
Cysique LA; Maruff P; Brew BJ, 2004, 'Prevalence and pattern of neuropsychological impairment in humanimmunodeficiency virus-infected/acquired immunodeficiency syndrome(HIV/AIDS) patients across pre- and post-highly active antiretroviraltherapy eras: A combined study of two cohorts', Journal of Neurovirology, vol. 10, pp. 350 - 357, http://dx.doi.org/10.1080/13550280490521078
2004
Guillemin GJ; Brew BJ, 2004, 'Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification', Journal of Leukocyte Biology, vol. 75, pp. 388 - 397, http://dx.doi.org/10.1189/jlb.0303114
2004
Churchill M; Sterjovski J; Gray L; Cowley D; Chatfield C; Learmont J; Sullivan JS; Crowe SM; Mills J; Brew BJ; Wesselingh SL; McPhee DA; Gorry PR, 2004, 'Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia', Journal of Infectious Diseases, vol. 190, pp. 2181 - 2186, http://dx.doi.org/10.1086/425585
2004
Brew BJ; Pemberton LA; Ray J, 2004, 'Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?', Journal of Neurovirology, vol. 10 Suppl 1, pp. 38 - 43
2004
Guillemin GJ; Brew BJ, 2004, 'Phenotypic differences and similarities between microglia, macrophage and pericyte (review)', Journal of Leukocyte Biology, vol. 75, pp. 388 - 397
2004
Newell ME; Hoy JF; Cooper S; De Graaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI, 2004, 'Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients', Cancer, vol. 100, pp. 2627 - 2636, http://dx.doi.org/10.1002/cncr.20300
2004
Cysique LA; Maruff P; Brew BJ, 2004, 'Antiretroviral therapy in HIV infection: are neurologically active drugs important?', Archives of Neurology, vol. 61, pp. 1699 - 1704, http://dx.doi.org/10.1001/archneur.61.11.1699
2004
Brew BJ, 2004, 'Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex', AIDS, vol. 18 Suppl 1, pp. S75 - S78
2004
Guillemin GJ; Croitoru-Lamoury J; Dormont D; Brew BJ, 2003, 'Involvement of quinolinic acid in chemokine production and chemokine receptor expression in human foetal astrocytes', Advances in Experimental Medicine and Biology, vol. 527, pp. 37 - 45
2003
Croitoru J; Guillemin GJ; Boussin F; Mognetti B; Gigout LI; Cheret A; Vaslin A; Le Grand AR; Brew BJ; Dormont J, 2003, 'Expressions of chemokines and their receptors in human and simian astrocytes: evidence for a central effect of TNF and IFN in CXCR4 and CCR5 modulation.', Glia, vol. 41, pp. 354 - 370, http://dx.doi.org/10.1002/glia.10181
2003
Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'A1-42 induces production of quinolinic acid by human macrophages and microglia', NeuroReport, vol. 14, pp. 165 - 181
2003
Guillemin GJ; Croitoru J; Dormont J; Armati PJ; Brew BJ, 2003, 'Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes: implications for brain inflammation in AIDS', Glia, vol. 41, pp. 371 - 381
2003
Guillemin GJ; Smith DG; Armati PJ; Brew BJ, 2003, 'Expression kynurenine pathway enzymes in human macrophages and microglia', Advances in Experimental Medicine and Biology, vol. 527, pp. 105 - 112
2003
Dore GJ; McDonald AM; Li Y; Kaldor JM; Brew BJ, 2003, 'Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, vol. 17, pp. 1539 - 1545, http://dx.doi.org/10.1097/00002030-200307040-00015
2003
Brew BJ; Tisch S; Law MG, 2003, 'Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy', AIDS, vol. 17, pp. 1094 - 1096, http://dx.doi.org/10.1097/00002030-200305020-00024
2003
Guillemin GJ; Croitoru J; Dormont D; Armati PJ; Brew BJ, 2003, 'Involvement of quinolinic acid in chemokine production and chemokine receptor expression in human fœtal astrocytes', Glia, vol. 41, pp. 371 - 381
2003
Guillemin GJ; Smith DG; Williams KR; Smythe GA; Dormont D; Brew BJ, 2003, 'Quinolinic acid in the pathogenesis of Alzheimer’s disease', Advances in Experimental Medicine and Biology, vol. 527, pp. 167 - 176
2003
Croitoru-Lamoury J; Guillemin GJ; Dormont D; Brew BJ, 2003, 'Quinolinic acid up-regulates chemokine production and chemokinereceptor expression in astrocytes', Advances in Experimental Medicine and Biology, vol. 527, pp. 37 - 45
2003
Guillemin GJ; Croitoru-Lamoury J; Dormont D; Armati PJ; Brew BJ, 2003, 'Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes', GLIA, vol. 41, pp. 371 - 381, http://dx.doi.org/10.1002/glia.10175
2003
Brew BJ; Tisch S; Law MG, 2003, 'HIV nucleoside neuropathy and HIV distal symmetrical neuropathy: relationships to serum lactate and plasma HIV viral load', AIDS, vol. 17, pp. 1094 - 1096
2003
Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'A beta I-42 induces production of quinolinic acid by human macrophagesand microglia', Neuroreport, vol. 14, pp. 2311 - 2315
2003
Guillemin GJ; Williams K; Smith DG; Smythe GA; Croitoru-Lamoury J; Brew BJ, 2003, 'Quinolinic acid in the pathogenesis of Alzheimer`s disease', Advances in Experimental Medicine and Biology, vol. 527, pp. 167 - 176, http://www.springer.com/series/5584
2003
Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'ABeta 1-42 Induces Production of Quinolinic Acid by Human Macrophases and Microglia.', Neuroreport, vol. 14, pp. 2311 - 2315, http://dx.doi.org/10.1097/00001756-200312190-00005
2003
Brew BJ, 2003, 'The peripheral nerve complications of human immunodeficiency virus (HIV) infection', Muscle and Nerve, vol. 28, pp. 542 - 552, http://dx.doi.org/10.1002/mus.10484
2003
Guillemin GJ; Smith DG; Smythe GA; Armati PJ; Brew BJ, 2003, 'Expression of the kynurenine pathway enzymes in human microglia and macrophages', Advances in Experimental Medicine and Biology, vol. 527, pp. 105 - 112
2003
Guillemin GJ; Brew BJ, 2002, 'Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease', Redox Report, vol. 7, pp. 199 - 206, http://dx.doi.org/10.1179/135100002125000550
2002
Loy CT; Brew BJ, 2002, 'Treatment of opportunistic infections and lymphoma in the nervous system.', Journal of HIV therapy, vol. 7, pp. 21 - 25
2002
Smythe GA; Braga O; Brew BJ; Grant RS; Guillemin GJ; Kerr SJ; Walker DW, 2002, 'Concurrent quantification of quinolinic, picolinic and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry', Analytical Biochemistry, vol. 301, pp. 21 - 26, http://dx.doi.org/10.1006/abio.2001.5490
2002
Guillemin GJ; Brew BJ, 2002, 'Implications of the kynurenine pathway and quinolinic acid in Alzheimer`s disease', Redox Report, vol. 7, pp. 1
2002
Bain M; Brew B; Coltheart M, 2002, 'Progressive peripheral dysgraphia in early posterior cortical atrophy', NEUROBIOLOGY OF AGING, vol. 23, pp. S39 - S40, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000177465300149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2002
Loy C; Brew BJ, 2002, 'Lymphona and opportunistic infections of the brain', Journal of Hiv Therapy, vol. 7, pp. 21 - 25
2002
Brew BJ, 2001, 'Markers of AIDS dementia complex: the role of cerebrospinal fluid assays', AIDS, vol. 15, pp. 1883 - 1884, http://dx.doi.org/10.1097/00002030-200109280-00020
2001
Lanier ER; Sturge G; McClernon D; Brown S; Halman M; Sacktor N; McArthur J; Atkinson JH; Clifford D; Price R; Simpson D; Torres G; Catalan J; Marder K; Power C; Hall C; Romero C; Brew BJ, 2001, 'HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with abacavir', AIDS, vol. 15, pp. 747 - 751, http://dx.doi.org/10.1097/00002030-200104130-00010
2001
Smit T; Wang B; Ng T; Osborne R; Brew BJ; Saksena NK, 2001, 'Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS Dementia Complex (ADC): evidence for neurotropic HIV variants.', Virology, vol. 279, pp. 509 - 526, http://dx.doi.org/10.1006/viro.2000.0681
2001
Smith DG; Guillemin GJ; Pemberton LA; Kerr SJ; Nath A; Smythe GA; Brew BJ, 2001, 'Quinolinic acid is produced by macrophages stimulated by platelet activating factor, NeF and Tat', Journal of Neurovirology, vol. 7, pp. 56 - 60, http://dx.doi.org/10.1080/135502801300069692
2001
Pemberton LA; Brew BJ, 2001, 'Cerebrospinal fluid S-100ß and its relationship with AIDS dementia complex.', Journal of Clinical Virology, vol. 22, pp. 249 - 253, http://dx.doi.org/10.1016/S1386-6532(01)00196-2
2001
Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ, 2001, 'Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection', Journal of Neurochemistry, vol. 78, pp. 842 - 853, http://dx.doi.org/10.1046/j.1471-4159.2001.00498.x
2001
Guillemin GJ; Kerr SJ; Pemberton LA; Smith DG; Smythe GA; Armati PJ; Brew BJ, 2001, 'IFN-b1b induces Kynurenine pathway metabolism in human macrophages:potential implications for multiple sclerosis treatment', Journal of Interferon and Cytokine Research, vol. 21, pp. 1097 - 1101, http://dx.doi.org/10.1089/107999001317205231
2001
Brew BJ, 2001, 'HTLV-I and HIV infections of the CNS in tropical areas [10]', Journal of Neurology Neurosurgery and Psychiatry, vol. 70, pp. 138, http://dx.doi.org/10.1136/jnnp.70.1.138
2001
Guillemin GJ; Smith DD; Kerr SJ; Smythe GA; Kapoor V; Armati P; Brew BJ, 2000, 'Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neutopathogenesis', Redox Report, pp. 108 - 111
2000
Brew BJ, 2000, 'Does HHV-8 have a neuroprotective role on the development of HIV encephalopathy? (letter)', Neurology, vol. 55, pp. 459 - 460, http://dx.doi.org/10.1212/WNL.55.3.459-a
2000
Brew BJ; Dore GJ, 2000, 'Decreasing incidence of CNS AIDS defining events associated with antiretroviral therapy (letter)', Neurology, vol. 55, pp. 1424 - 1424, http://dx.doi.org/10.1212/WNL.55.9.1424
2000
Dore GJ; Brew BJ, 2000, 'Response to Eberly et al., Kaposi¿s sarcoma and central nervous system disease: a real association or an artifact of the control group? (letter)', AIDS, vol. 14, pp. 2631 - 2632, http://dx.doi.org/10.1097/00002030-200011100-00037
2000
Grulich AE; Dore GJ; Brew BJ, 2000, 'Human herpesvirus 8 and protection from AIDS dementia complex', Herpes, vol. 7, pp. 38 - 40
2000
Guillemin GJ; Smith DG; Kerr SJ; Smythe GA; Kapoor V; Armati P; Brew BJ, 2000, 'Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis', Redox Report, vol. 5, pp. 108 - 111, http://dx.doi.org/10.1179/135100000101535375
2000
Cunningham PH; Smith DD; Satchell C; Cooper DA; Brew BJ, 2000, 'Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.', AIDS, vol. 14, pp. 1949 - 1954, http://dx.doi.org/10.1097/00002030-200009080-00010
2000
Brew BJ, 1999, 'AIDS dementia complex', Neurologic Clinics, vol. 17, pp. 861 - 881, http://dx.doi.org/10.1016/S0733-8619(05)70170-5
1999
Dore GJ; Correll PK; Li Y; Kaldor JM; Cooper DA; Brew BJ, 1999, 'Changes to AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, vol. 13, pp. 1249 - 1253, http://dx.doi.org/10.1097/00002030-199907090-00015
1999
Guillemin GJ; Kerr SJ; Smythe GA; Armati P; Brew BJ, 1999, 'Kynurenine pathway metabolism in human astrocytes', Advances in Experimental Medicine and Biology, vol. 467, pp. 125 - 131
1999
Brennan JD; Pell MF; Brew BJ, 1999, 'HIV-related primary cerebral lymphoma: the role of stereotactic biopsy', Journal of Clinical Neuroscience, vol. 6, pp. 217 - 220, http://dx.doi.org/10.1016/S0967-5868(99)90506-4
1999
Markus R; Brew BJ, 1998, 'HIV-1 peripheral neuropathy and combination antiretroviral therapy', Lancet, vol. 352, pp. 1906 - 1907, http://dx.doi.org/10.1016/S0140-6736(05)60397-2
1998
Kerr SJ; Pemberton LA; Guillemin GJ; Smythe G; Brew BJ, 1998, 'Interferon-beta induces kynurenine pathway metabolism inhuman macrophages', NEUROLOGY, vol. 50, pp. A34 - A34, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000073240900095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1998
Brew BJ; Gisslen M; Svennerholm B; Fuchs D; Hagberg L, 1998, 'Neurological efficacy of stavudine, zidovudine, and lamivudine (multiple letters) [2]', Lancet, vol. 352, pp. 402 - 403
1998
Kerr SJ; Amarti PJ; Guilbaud G; Brew BJ, 1998, 'Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex', AIDS, vol. 12, pp. 355 - 363, http://dx.doi.org/10.1097/00002030-199804000-00003
1998
Mcphee D; Greenway AL; Holloway G; Smith KR; Deacon N; Pemberton LA; Brew BJ, 1998, 'Anomalies in Nef expression within the central nervous system of HIV-1 positive individuals/AIDS patients with or without AIDS dementia complex', Journal of Neurovirology, vol. 4, pp. 291 - 300, http://dx.doi.org/10.3109/13550289809114530
1998
Szeto ER; Freund J; Brew BJ; Loder A; Griffiths M, 1998, 'Cerebral perfusion scanning in treating AIDS dementia', Journal of Nuclear Medicine, vol. 39, pp. 298 - 302
1998
Dore GJ; Grulich AE; Law MG; Brew BJ; Kaldor JM, 1998, 'Kaposi¿s sarcoma and protection from AIDS dementia complex', AIDS, vol. 12, pp. 2354 - 2355
1998
Brew BJ, 1998, 'Evaluation and management of intracranial mass lesions in AIDS - Report of the Quality Standards Subcommittee of the American Academy of Neurology', Neurology, vol. 51, pp. 1232 - 1233
1998
Brew BJ, 1998, 'Neurological efficacy of stavudine, zidovudine, and lamivudine', Lancet, vol. 352, pp. 402 - 402, http://dx.doi.org/10.1016/S0140-6736(05)60498-9
1998
Adcock JE; Davies MJ; Turner J; Pell MF; Brew BJ, 1997, 'Progressive multifocal leukoencephalopathy: a retrospective study of 30 cases', Journal of Clinical Neuroscience, vol. 4, pp. 463 - 468, http://dx.doi.org/10.1016/S0967-5868(97)90036-9
1997
Dore GJ; Law MG; Brew BJ, 1997, 'Prospective analysis of seizures occurring in human immunodeficiency virus type-1 infection', Journal of Neuro-AIDS, vol. 1, pp. 59 - 69, http://dx.doi.org/10.1300/J128v01n04_06
1997
Dunbar N; Pemberton L; Perdices M; Brew BJ, 1997, 'Clinical markers of the presence of dementia and neuropsychological impairment in hiv infection', Journal of Neuro-AIDS, vol. 1, pp. 31 - 48, http://dx.doi.org/10.1300/J128v01n04_04
1997
Brew BJ, 1997, 'The cellular basis of central nervous HIV-1 infection and the AIDS dementia complex - Price,RW, Sidtis,JJ', VENEREOLOGY-THE INTERDISCIPLINARY INTERNATIONAL JOURNAL OF SEXUAL HEALTH, vol. 10, pp. 126 - 126, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XV34400011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1997
Kerr SJ; Armati P; Pemberton LA; Smythe GA; Tattam B; Brew BJ, 1997, 'Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages', Neurology, vol. 49, pp. 1671 - 1681, http://dx.doi.org/10.1212/WNL.49.6.1671
1997
Bradley TP; Brew BJ, 1997, 'HIV type-1-related transient neurologic deficits [2] (multiple letters)', American Journal of Medicine, vol. 103, pp. 250
1997
Pemberton LA; Kerr SJ; Smythe GA; Brew BJ, 1997, 'Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha', Journal of Interferon and Cytokine Research, vol. 17, pp. 589 - 595, http://dx.doi.org/10.1089/jir.1997.17.589
1997
Markus R; Brew BJ; Turner J; Pell MF, 1997, 'Successful outcome with aggressive treatment of acute haemorrhagic leukoencephalitis', Journal of Neurology Neurosurgery and Psychiatry, vol. 63, pp. 551 - 551, http://dx.doi.org/10.1136/jnnp.63.4.551
1997
Brew BJ; Pemberton LA; Cunningham PH; Law MG, 1997, 'Levels of human imunodeficiency virus type RNA in cerebrospinal fluid correlae with AIDS dementia stage', Journal of Infectious Diseases, vol. 175, pp. 963 - 966, http://dx.doi.org/10.1086/514001
1997
Dunbar N; Brew B, 1997, 'Neuropsychological Dysfunction in HIV Infection:A Review', Journal of neuro-AIDS, vol. 1, pp. 73 - 102
1997
Pemberton LA; Kerr SJ; Brew BJ, 1997, 'HIV-1 gp120 does not induce quinolinic acid production by macrophages', Journal of Neurovirology, vol. 3, pp. 86 - 87, http://dx.doi.org/10.3109/13550289709015798
1997
Pemberton LA; Kerr SJ; Smythe GA; Brew BJ, 1997, 'Quinolinic acid production by macrophages stimulate with interferon y tumour necrosis factor a and interferon a', Journal of Interferon and Cytokine Research, vol. 17, pp. 589 - 595
1997
Kerr SJ; Armati PJ; Pemberton LA; Smythe G; Brew BJ, 1997, 'Kynurenine pathway inhibition with 6-chloro-D-tryptophan reduces neurotoxicity of HIV-1 infected macrophage supernatants', NEUROLOGY, vol. 48, pp. 2008 - 2008, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XG87100226&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1997
Cunningham AL; Naif H; Saksena N; Lynch G; Chang JW; Li S; Jozwiak R; Alali M; Wang B; Fear W; Sloane A; Pemberton LA; Brew BJ, 1997, 'HIV infection of macrophages and the pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype', Journal of Leukocyte Biology, vol. 62, pp. 117 - 125, http://dx.doi.org/10.1002/jlb.62.1.117
1997
Dick AD; Pell MF; Brew BJ; Foulcher E; Sedgwick JD, 1997, 'Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurological disease', AIDS, vol. 11, pp. 1699 - 1708, http://dx.doi.org/10.1097/00002030-199714000-00006
1997
Field AS; Marriot DJ; Milliken ST; Brew BJ; Canning EU; Kench JG; Darveniza P; Harkness JL, 1996, 'Myositis associated with a newly describes microsporidian Trachipleistophora hominis, in a patient with AIDS', Journal of Clinical Microbiology, vol. 34, pp. 2803 - 2811
1996
Brew BJ; Wesselingh SL; Gonzales M; Heyes MP; Price RW, 1996, 'Managing HIV. Part 3: Mechanisms of diseases. 3.7 How HIV leads to neurological disease.', Med J Aust, vol. 164, pp. 233 - 234, https://www.ncbi.nlm.nih.gov/pubmed/8604196
1996
Wright EJ; Brew BJ; Currie JN; McArthur JC, 1996, '5.4 HIV-induced neurological disease', Medical Journal of Australia, vol. 164, pp. 414 - 417
1996
Brew BJ; Dunbar N; Druett J; Freund J; Ward PB, 1996, 'Pilot study of the efficacy of atevirdine in the treatment of AIDS dementia complex', AIDS, vol. 10, pp. 1357 - 1360, http://dx.doi.org/10.1097/00002030-199610000-00007
1996
Jones PD; Beaman MH; Brew BJ, 1996, '5.5 HIV and opportunistic neurological infections', Medical Journal of Australia, vol. 164, pp. 418 - 421
1996
Norton GR; Sweeney J; Marriott D; Law MG; Brew BJ, 1996, 'Association between HIV distal symmetric polyneuropathy and Mycobacterium avium complex infection', Journal of Neurology Neurosurgery and Psychiatry, vol. 61, pp. 606 - 609, http://dx.doi.org/10.1136/jnnp.61.6.606
1996
Brew BJ; Dunbar N; Druett J; Freund J; Ward PB, 1996, 'Pilot study of the efficacy of atervidine in ADC', AIDS, vol. 10, pp. 1357 - 1360
1996
Kerr SJ; Armati P; Brew BJ, 1996, 'Neurocytotoxicity of quinolinic acid in human brain cultures', Journal of Neurovirology, vol. 1, pp. 375 - 380, http://dx.doi.org/10.3109/13550289509111027
1996
Brew BJ; Wesselingh SL; Gonzales M; Heyes MP; Price RW, 1996, 'How HIV leads to neurological disease', Medical Journal of Australia, vol. 164, pp. 233 - 234
1996
Norton GR; Sweeney J; Marriott D; Law MG; Brew BJ, 1996, 'An association between HIV distal symmetrical polyneuropathy and Mycobacterium Avium complex infection', Journal of Neurology Neurosurgery and Psychiatry, pp. 606 - 609
1996
Dunbar N; Brew B, 1996, 'Neuropsychological dysfunction in HIV infection: A review', Journal of Neuro-AIDS, vol. 1, pp. 73 - 102, http://dx.doi.org/10.1300/J128v01n03_05
1996
Brew BJ; Evans L; Byrne C; Pemberton LA; Hurren L, 1996, 'The relationship between AIDS demtia complex and the presence of macriphage tropic and non syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid', Journal of Neurovirology, vol. 2, pp. 152 - 157, http://dx.doi.org/10.3109/13550289609146877
1996
Wright EJ; Brew BJ; Currie JN; McArthur JC, 1996, 'Managing HIV .5. Treating secondary outcomes - HIV-induced neurological disease', MEDICAL JOURNAL OF AUSTRALIA, vol. 164, pp. 414 - 417, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122090.x
1996
Jones PD; Beaman MH; Brew BJ, 1996, 'Managing HIV .5. Treating secondary outcomes - HIV and opportunistic neurological infections', MEDICAL JOURNAL OF AUSTRALIA, vol. 164, pp. 418 - 421, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122091.x
1996
Brew BJ; Corbeil J; Pemberton LA; Evans L; Saito K; Penny R; Cooper DA; Heyes MP, 1996, 'Quinolinic acid production by macrophages infected with HIV-1 isolates from patients with and without AIDS dementia complex', Journal of Neurovirology, vol. 1, pp. 369 - 374
1996
Brew BJ; Glass JD; McArthur JC, 1996, 'Human immunodeficiency virus in brain and correlation with dementia [5]', Annals of Neurology, vol. 39, pp. 828 - 829, http://dx.doi.org/10.1002/ana.410390631
1996
Brew BJ; Miller J, 1996, 'Human immunodeficiency virus type 1 related transient neurologic deficits', American Journal of Medicine, vol. 101, pp. 257 - 261, http://dx.doi.org/10.1016/S0002-9343(96)00123-4
1996
Brew BJ; Rosenblum M; Cronin K; Price RW, 1995, 'AIDS dementia complex and HIV‐1 brain infection: Clinical‐virological correlations', Annals of Neurology, vol. 38, pp. 563 - 570, http://dx.doi.org/10.1002/ana.410380404
1995
Brew BJ; Rosenblum M; Cronin K; Price R, 1995, 'The AIDS dementia complex and human immunodeficiency virus type 1 brian infection: clinical-virological correlations', Annals of Neurology, pp. 563 - 570
1995
Brew BJ; Corbeil J; Pemberton L; Evans L; Saito K; Penny R; Cooper DA; Heyes MP, 1995, 'Quinolinic acid production is related to macrophage tropic isolates of HIV-1.', Journal of neurovirology, vol. 1, pp. 369 - 374, http://dx.doi.org/10.3109/13550289509111026
1995
Davies MJ; Pell MF; Brew BJ, 1995, 'Stereotactic biopsy of cerebral lesions in AIDS', Journal of Clinical Neuroscience, vol. 2, pp. 40 - 44
1995
Davies MA; Pell MF; Brew BJ, 1995, 'Stereotactic biopsy of cerebral lesions in acquired immunodeficiency syndrome', Journal of Clinical Neuroscience, vol. 2, pp. 40 - 44, http://dx.doi.org/10.1016/0967-5868(95)90028-4
1995
Davies MJ; Pell MF; Brew BJ, 1995, 'Stereotectic biopsy of cerebral lesions in AIDS', Journal of Clinical Neuroscience, vol. 2, pp. 40 - 44
1995
Brew BJ; Paul MO; Nakajima G; Khan A; Gallardo H; Price RW, 1994, 'Cerebrospinal fluid HIV-1 p24 antigen and culture: Sensitivity and specificity for AIDS-dementia complex', Journal of Neurology, Neurosurgery and Psychiatry, vol. 57, pp. 784 - 789, http://dx.doi.org/10.1136/jnnp.57.7.784
1994
Milstien S; Sakai N; Brew BJ; Krieger C; Vickers JH; Saito K; Heyes MP, 1994, 'Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases', Journal of Neurochemistry, vol. 63, pp. 1178 - 1180
1994
Brew BJ, 1994, 'The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathy', Current Opinion in Neurology, vol. 7, pp. 209 - 216, http://dx.doi.org/10.1097/00019052-199406000-00006
1994
Brew BJ, 1994, 'HIV dementia', Neurology, vol. 44, pp. 2214
1994
Clezy K; Sirisanthana T; Sirisanthana V; Brew B; Cooper DA, 1994, 'Late manifestations of HIV in Asia and the Pacific', AIDS, vol. 8
1994
Brew BJ, 1994, 'Optimal Treatment of HIV-1-Induced CNS Neurological Disorders', CNS Drugs, vol. 2, pp. 292 - 300, http://dx.doi.org/10.2165/00023210-199402040-00005
1994
Kelleher AD; Brew BJ; Milliken ST, 1994, 'Intractable headache as the presenting complaint of AIDS-related lymphoma confined to bone', Journal of Acquired Immune Deficiency Syndromes, vol. 7, pp. 629 - 630
1994
BREW BJ; CURRIE JN, 1993, 'COULD IT BE HIV .8. HIV-RELATED NEUROLOGICAL DISEASE', MEDICAL JOURNAL OF AUSTRALIA, vol. 158, pp. 104 - 108, http://dx.doi.org/10.5694/j.1326-5377.1993.tb137536.x
1993
Brew BJ; Miller J, 1993, 'Human immunodeficiency virus-related headache', Neurology, vol. 43, pp. 1098 - 1100
1993
Quinn D; Pocock N; Freund J; Kelleher A; Penny R; Brew B, 1993, 'Radionuclide hepatobiliary scanning in patients with AIDS-related sclerosing cholangitis', Clinical Nuclear Medicine, vol. 18, pp. 417 - 422, http://dx.doi.org/10.1097/00003072-199305000-00010
1993
Brew BJ, 1993, 'The pathogenesis of the neurological complications of HIV-1 infection', Genitourinary Medicine, vol. 69, pp. 333 - 340
1993
Brew BJ; Currie JN, 1993, 'HIV-related neurological disease', Medical Journal of Australia, vol. 158, pp. 104 - 108
1993
Shaskan EG; Brew BJ; Rosenblum M; Thompson RM; Price RW, 1992, 'Increased Neopterin Levels in Brains of Patients with Human Immunodeficiency Virus Type 1 Infection', Journal of Neurochemistry, vol. 59, pp. 1541 - 1546, http://dx.doi.org/10.1111/j.1471-4159.1992.tb08471.x
1992
Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA, 1992, 'Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS', Annals of Internal Medicine, vol. 117, pp. 106 - 111, http://dx.doi.org/10.7326/0003-4819-117-2-106
1992
Rosenblum MK; Brew BJ; Hahn B; Shaw G; Haase A; Maroushek S; Price RW, 1992, 'Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome', Human Pathology, vol. 23, pp. 513 - 519, http://dx.doi.org/10.1016/0046-8177(92)90128-P
1992
Brew BJ; Perdices M, 1992, 'HIV nomenclature', Neurology, vol. 42, pp. 265, http://dx.doi.org/10.1212/WNL.42.1.265
1992
Brew BJ, 1992, 'Central and peripheral nervous system abnormalities', Medical Clinics of North America, vol. 76, pp. 63 - 81, http://dx.doi.org/10.1016/S0025-7125(16)30371-6
1992
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP, 1992, 'Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and β2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients', Journal of Neuroimmunology, vol. 40, pp. 71 - 80, http://dx.doi.org/10.1016/0165-5728(92)90214-6
1992
Brew BJ; Bhalla RB; Paul M; Sidtis JJ; Keilp JJ; Sadler AE; Gallardo H; McArthur JC; Schwartz MK; Price RW, 1992, 'Cerebrospinal fluid β2-microglobulin in patients with AIDS dementia complex: An expanded series including response to zidovudine treatment', AIDS, vol. 6, pp. 461 - 465
1992
Brew BJ, 1992, 'Medical management of AIDS patients. Central and peripheral nervous system abnormalities.', Med Clin North Am, vol. 76, pp. 63 - 81, http://dx.doi.org/10.1016/s0025-7125(16)30371-6
1992
Reimund E; Martin AA; Emerich DF; Sanberg PR; James Brew B; Everall I; Luthert P; Lantos P, 1991, 'Neuronal loss in frontal cortex in HIV infection', The Lancet, vol. 338, pp. 129 - 130, http://dx.doi.org/10.1016/0140-6736(91)90131-8
1991
Kaplan JE; Litchfield B; Rouault C; Lairmore MD; Luo CC; Williams L; Brew BJ; Price RW; Janssen R; Stoneburner R, 1991, 'HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient.', Neurology, vol. 41, pp. 192 - 197, http://dx.doi.org/10.1212/wnl.41.2_part_1.192
1991
Price RW; Sidtis JJ; Brew BJ, 1991, 'AIDS Dementia Complex and HIV‐1 Infection: A View From the Clinic', Brain Pathology, vol. 1, pp. 155 - 162, http://dx.doi.org/10.1111/j.1750-3639.1991.tb00655.x
1991
Janssen RS; Kaplan JE; Khabbaz RF; Hammond R; Lechtenberg R; Lairmore M; Chiasson MA; Punsalang A; Roberts B; Mc Kendall RR; Rosenblum M; Brew B; Farraye J; Howley DJ; Feraru E; Sparr S; Vecchio J; Silverman M; Mc Harg M; Gorin B; Rugg DR; Grenell S; Trimble B; Bruining K; Guha S; Amaraneni P; Price RW, 1991, 'HTLV–I—associated myelopathy/tropical spastic paraparesis in the United States', Neurology, vol. 41, pp. 1355 - 1357
1991
KAPLAN JE; LITCHFIELD B; ROUAULT C; LAIRMORE MD; LUO CC; WILLIAMS L; BREW BJ; PRICE RW; JANSSEN R; STONEBURNER R; OU CY; FOLKS T; DE B, 1991, 'HTLV-I ASSOCIATED MYELOPATHY ASSOCIATED WITH BLOOD-TRANSFUSION IN THE UNITED-STATES - EPIDEMIOLOGIC AND MOLECULAR EVIDENCE LINKING DONOR AND RECIPIENT', NEUROLOGY, vol. 41, pp. 192 - 197, http://dx.doi.org/10.1212/WNL.41.2_Part_1.192
1991
Brew BJ, 1991, 'MS-like leukoencephalopathy in HIV-1', Neurology, vol. 41, pp. 1166, http://dx.doi.org/10.1212/WNL.41.7.1166-a
1991
Heyes MP; Brew B; Martin A; Markey SP; Price RW; Bhalla RB; Salazar A, 1991, 'Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome', Advances in Experimental Medicine and Biology, vol. 294, pp. 687 - 690
1991
Portegies P; Brew BJ, 1991, 'Update on HIV-related neurological illness.', AIDS (London, England), vol. 5 Suppl 2
1991
Heyes MP; Brew BJ; Martin A; Price RW; Salazar AM; Sidtis JJ; Yergey JA; Mouradian MM; Sadler AE; Keilp J; Rubinow D; Markey SP, 1991, 'Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status', Annals of Neurology, vol. 29, pp. 202 - 209, http://dx.doi.org/10.1002/ana.410290215
1991
Kaplan JE; Litchfield B; Rouault C; Lairmore MD; Luo CC; Williams L; Brew BJ; Price RW; Janssen R; Stoneburner R; Ou CY; Folks T; De B, 1991, 'HTLV-I—associated myelopathy associated with blood transfusion in the United States: Epidemiologic and molecular evidence linking donor and recipient', Neurology, vol. 41, pp. 192 - 197
1991
Brew BJ; Cooper DA, 1991, 'Neurological manifestations of HIV-1 infection [10]', AIDS, vol. 5, pp. 609, http://dx.doi.org/10.1097/00002030-199105000-00030
1991
Krown SE; Gold JWM; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ, 1990, 'Interferon-α with zidovudine: Safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)', Annals of Internal Medicine, vol. 112, pp. 812 - 821, http://dx.doi.org/10.7326/0003-4819-112-11-812
1990
Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW, 1990, 'Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection', Annals of Neurology, vol. 28, pp. 556 - 560, http://dx.doi.org/10.1002/ana.410280413
1990
Price RW; Brew BJ; Rosenblum M, 1990, 'The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction.', Research publications - Association for Research in Nervous and Mental Disease, vol. 68, pp. 269 - 290
1990
BREW BJ, 1990, 'Prognosis of patients … myelopathy of unknown origin', Australian and New Zealand Journal of Medicine, vol. 20, pp. 189 - 189, http://dx.doi.org/10.1111/j.1445-5994.1990.tb01303.x
1990
BREW BJ, 1990, 'REPLY', Australian and New Zealand Journal of Medicine, vol. 20, pp. 630 - 630, http://dx.doi.org/10.1111/j.1445-5994.1990.tb01333.x
1990
Brew BJ; Bhalla RB; Fleisher M; Paul M; Khan A; Schwartz MK; Price RW, 1989, 'Cerebrospinal fluid β2microglobulin in patients infected with human immunodeficiency virus', Neurology, vol. 39, pp. 830 - 834
1989
BREW BJ; PERDICES M; DARVENIZA P; EDWARDS P; WHYTE B; BURKE WJ; GARRICK R; O'SULLIVAN D; PENNY R; COOPER DA, 1989, 'THE NEUROLOGICAL FEATURES OF EARLY AND ‘LATENT’ HUMAN IMMUNODEFICIENCY VIRUS INFECTION', Australian and New Zealand Journal of Medicine, vol. 19, pp. 700 - 705, http://dx.doi.org/10.1111/j.1445-5994.1989.tb00339.x
1989
Brew BJ; Hardy W; Zuckerman E; Chien N; Paul M; Rosenblum M; Gadler H; Vahlne A; Gold J; Armstrong DA; Price RW, 1989, 'AIDS‐related vacuolar myelopathy is not associated with coinfection by human T‐lymphotropic virus Type I', Annals of Neurology, vol. 26, pp. 679 - 681, http://dx.doi.org/10.1002/ana.410260515
1989
Rosenblum M; Scheck AC; Cronin K; Brew BJ; Khan A; Pau M; Price RW, 1989, 'Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord', Neurology, vol. 39, pp. 892 - 896
1989
ROSENBLUM M; SCHECK A; CRONIN K; KHAN A; PAUL M; BREW B; PRICE RW, 1989, 'DISSOCIATION OF VACUOLAR MYELOPATHY AND DETECTABLE HIV-1 INFECTION OF THE SPINAL-CORD', LABORATORY INVESTIGATION, vol. 60, pp. A80 - A80, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1989R895900485&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1989
Brew BJ, 1989, 'Acute encephalopathy caused by human immunodeficiency virus apparently responsive to zidovudine', Medical Journal of Australia, vol. 151, pp. 725 - 726
1989
Price RW; Brew B, 1988, 'Management of the neurologic complications of HIV infection and AIDS.', Infectious disease clinics of North America, vol. 2, pp. 359 - 372
1988
HOUANG MTW; STERN M; BREW B; PELL M; DARVENIZA P, 1988, 'Magnetic Resonance Imaging (MRI) Appearances of Syringohydromyelia', Australasian Radiology, vol. 32, pp. 172 - 177, http://dx.doi.org/10.1111/j.1440-1673.1988.tb02717.x
1988
HOUANG MTW; STERN M; BREW B; PELL M; SHEEHY J, 1988, 'Magnetic Resonance Imaging (MRI) of Pseudosyrinxes', Australasian Radiology, vol. 32, pp. 178 - 183, http://dx.doi.org/10.1111/j.1440-1673.1988.tb02718.x
1988
Aronow HA; Brew BJ; Price RW, 1988, 'The management of the neurological complications of HIV infection and AIDS', AIDS, vol. 2
1988
Brew BJ; Rosenblum M; Price RW, 1988, 'AIDS dementia complex and primary HIV brain infection', Journal of Neuroimmunology, vol. 20, pp. 133 - 140, http://dx.doi.org/10.1016/0165-5728(88)90144-0
1988
Brew BJ; Rosenblum M; Price RW, 1988, 'Pathogenetic implications of neuropathological findings in the AIDS dementia complex', Psychopharmacology Bulletin, vol. 24, pp. 307 - 310
1988
PRICE RW; BREW B, 1988, 'Infection of the Central Nervous System by Human Immunodeficiency Virus Role of the Immune System in Pathogenesis', Annals of the New York Academy of Sciences, vol. 540, pp. 162 - 175, http://dx.doi.org/10.1111/j.1749-6632.1988.tb27059.x
1988
Brew BJ; Sidtis JJ; Rosenblum M; Price RW, 1988, 'AIDS dementia complex', Journal of the Royal College of Physicians of London, vol. 22, pp. 140 - 144
1988
Brew BJ; Price RW, 1988, 'Another Retroviral Disease of the Nervous System', New England Journal of Medicine, vol. 318, pp. 1195 - 1197, http://dx.doi.org/10.1056/NEJM198805053181809
1988
Price RW; Brew B; Sidtis J; Rosenblum M; Scheck AC; Cleary P, 1988, 'The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex', Science, vol. 239, pp. 586 - 592, http://dx.doi.org/10.1126/science.3277272
1988
Price RW; Brew BJ, 1988, 'The aids dementia complex', Journal of Infectious Diseases, vol. 158, pp. 1079 - 1083, http://dx.doi.org/10.1093/infdis/158.5.1079
1988
Brew BJ; Garrick R, 1987, 'Gliomas presenting outside the central nervous system.', Clinical and experimental neurology, vol. 23, pp. 111 - 117
1987
Brew BJ; O'Sullivan DJ; Darveniza P; Selby G; Fryer J; Evans W, 1987, 'Neoplastic angioendotheliosis.', Clinical and experimental neurology, vol. 23, pp. 119 - 126
1987
Brew BJ; Garrick R; Connelley TJ, 1987, 'Lumboperitoneal shunting as a cause of visual loss in benign intracranial hypertension.', Clinical and experimental neurology, vol. 23, pp. 233 - 235
1987
BREW BJ, 1986, 'DIAGNOSIS OF WERNICKE'S ENCEPHALOPATHY', Australian and New Zealand Journal of Medicine, vol. 16, pp. 676 - 678, http://dx.doi.org/10.1111/j.1445-5994.1986.tb00011.x
1986
Tuck RR; Brew BJ; Britton AM; Loewy J, 1984, 'Alcohol and Brain Damage', British Journal of Addiction, vol. 79, pp. 251 - 259, http://dx.doi.org/10.1111/j.1360-0443.1984.tb00273.x
1984
Conference Abstracts
add
Zeng G; Penninkilampi R; Chaganti J; Montagnese S; Brew B; Danta M, 2019, 'A systematic review and meta-analysis of the efficacy of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, Vol. 70, pp. E698 - E699, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1016/S0618-8278(19)31392-1
2019
Rofe CJF; Garrick R; Burke D; Brew BJ; Tomlinson SE, 2019, 'BREAKING THE CYCLE OF CHRONIC DAILY HEADACHE WITH A LOW-DOSE SUBCUTANEOUS LIGNOCAINE AND KETAMINE INFUSION', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, Sydney, AUSTRALIA, Vol. 90, presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), Sydney, AUSTRALIA, 21 May 2019 - 24 May 2019, http://dx.doi.org/10.1136/jnnp-2019-anzan.77
2019
Zeng G; Penninkilampi R; Chaganti J; Montagnese S; Brew B; Danta M, 2019, 'A systematic review and meta-analysis of the efficacy of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 55 - 55, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Barnes SL; Brew BJ, 2019, 'ACUTE CEREBELLAR ATAXIA FOLLOWING EPSTEIN- BARR VIRUS INFECTION', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, Sydney, AUSTRALIA, Vol. 90, presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), Sydney, AUSTRALIA, 21 May 2019 - 24 May 2019, http://dx.doi.org/10.1136/jnnp-2019-anzan.37
2019
Asahchop E; Branton W; Zochodne D; Brew B; Gill J; Power C, 2018, 'microRNA-455-3p predicts HIV-associated symptomatic distal sensory polyneuropathy and suppresses NGF expression in human neurons', in JOURNAL OF NEUROIMMUNE PHARMACOLOGY, SPRINGER, Vol. 13, pp. S2 - S2, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429149100007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2018
Cysique L; Juge L; Lennon M; Gates T; Jones S; Lovelace M; Rae C; Johnson T; Nath A; Brew B, 2018, 'HIV Brain Latency May Directly Suppress Brain Cellular Energy', in JOURNAL OF NEUROVIROLOGY, SPRINGER, Chicago, IL, Vol. 24, pp. S19 - S19, presented at Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and the Society-on-NeuroImmune-Pharmacology (SNIP), Chicago, IL, 10 April 2018 - 14 April 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000434755400066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Asahchop E; Branton W; Zochodne D; Brew B; Gill J; Power C, 2018, 'microRNA-455-3p predicts HIV-associated symptomatic distal sensory polyneuropathy and suppresses NGF expression in human neurons', in JOURNAL OF NEUROVIROLOGY, SPRINGER, Chicago, IL, Vol. 24, pp. S2 - S2, presented at Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and the Society-on-NeuroImmune-Pharmacology (SNIP), Chicago, IL, 10 April 2018 - 14 April 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000434755400007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2018
Lovelace M; Croitoru-Lamoury J; Lamoury FMJ; Walters E; Suzuki K; Walker D; Jones SP; Taylor R; Brew BJ, 2017, 'The kynurenine pathway of tryptophan metabolism modulates neural stem cell proliferation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, MS Res Australia, Sydney, AUSTRALIA, Vol. 23, pp. NP27 - NP27, presented at Progress in MS Research Conference, MS Res Australia, Sydney, AUSTRALIA, 11 October 2017 - 13 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200074&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2017
Lovelace M; Sardesai V; Varney B; Guillemin GJ; Brew BJ, 2017, 'Laquinimod as a regulator of Kynurenine Pathway in Multiple Sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, MS Res Australia, Sydney, AUSTRALIA, Vol. 23, pp. NP27 - NP27, presented at Progress in MS Research Conference, MS Res Australia, Sydney, AUSTRALIA, 11 October 2017 - 13 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Gott C; Gates T; Dermody N; Brew B; Cysique L, 2016, 'Cognitive Change Trajectories in Virally Suppressed HIV-Infected Individuals Suggest High Prevalence of Ongoing Disease Activity', in JOURNAL OF NEUROVIROLOGY, SPRINGER, Toronto, CANADA, Vol. 22, pp. S24 - S25, presented at 14th International Symposium on NeuroVirology, Toronto, CANADA, 25 October 2016 - 28 October 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394093700051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2016
Conference Papers
add
Nir TM; Lam HY; Ananworanich J; Boban J; Brew BJ; Cysique L; Fouche JP; Kuhn T; Porges ES; Law M; Paul RH; Thames A; Woods AJ; Valcour VG; Thompson PM; Cohen RA; Stein DJ; Jahanshad N, 2019, 'Effects of Diffusion MRI Model and Harmonization on the Consistency of Findings in an International Multi-cohort HIV Neuroimaging Study', in Mathematics and Visualization, pp. 203 - 215, http://dx.doi.org/10.1007/978-3-030-05831-9_17
2019
Cysique LA; Juge L; Brew BJ; Rae C, 2015, 'DECREASED CELLULAR ENERGY IN THE BRAIN FRONTAL WHITE MATTER IS ASSOCIATED WITH PAST IMMUNOSUPPRESION IN CHRONIC HIV INFECTION', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A73 - A74, http://dx.doi.org/10.1136/sextrans-2015-052270.196
2015
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ, 2014, 'Involvement of the kynurenine pathway in human glioma pathophysiology', in PLoS ONE, http://dx.doi.org/10.1371/journal.pone.0112945
2014
Lim CK; Sundaram G; Brew BJ; Guillemin GJ, 2013, 'Preventing Quinolinic Acid-Induced Toxicity in Oligodendrocytes with Antagonizing Monoclonal Antibodies and Kynurenine Pathway Inhibitors', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Kyoto, JAPAN, pp. 959 - 960, presented at 6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, JAPAN, 06 November 2013 - 08 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000337854400200&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Lu G; Brew B; Siefried K; Draper B; Cysique L, 2013, 'Moderate neurocognitive decline can be detected over a four-month period using the HIV-dementia scale', in JOURNAL OF NEUROVIROLOGY, SPRINGER, Washington, DC, pp. S51 - S51, presented at 12th International Symposium on NeuroVirology, Washington, DC, 29 October 2013 - 02 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325777200107&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Lim CK; Stankovic RK; Wu W; Adams S; Brew BJ; Guillemin GJ, 2011, 'Involvement of the Kynurenine Pathway in Multiple Sclerosis Progression: the Link between Neuroinflammation and Neurodegeneration', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Singapore, SINGAPORE, pp. 534 - 535, presented at 4th Congress of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), Singapore, SINGAPORE, 28 August 2011 - 30 August 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000302289900095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Clifford D; Nath A; Cinque P; Brew BJ; Workman A; Gorelik L; Zhao J; Duda P, 2011, 'Mefloquine Treatment in Patients with Progressive Multifocal Leukoencephalopathy (PML)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, Honolulu, HI, pp. A28 - A28, presented at 63rd AAN Annual Meeting, Honolulu, HI, 09 April 2011 - 16 April 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288149300095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Sundaram G; Lim CK; Brew BJ; Guillemin GJ, 2011, 'Potential Activity of Kynurenine Pathway Modulators for Multiple Sclerosis Targeted Therapeutics', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Singapore, SINGAPORE, pp. 535 - 535, presented at 4th Congress of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), Singapore, SINGAPORE, 28 August 2011 - 30 August 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000302289900096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Cysique LA; Moffat K; Fox E; Brew BJ; Rae CD, 2010, 'Frontal white matter and Posterior Cingulate abnormalities metabolite abnormalities in older and clinically stable HIV+ individuals', in Small D (ed.), Australian Neurosciences Society Annual Scientific Meeting 2010, ANS, Sydney, pp. 67 - 67, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 - 03 February 2010
2010
Cysique LA; Myung-Lee J; Lane T; Moffat K; Davies N; Carr A; Brew BJ; Rae C, 2010, 'Glutamate excitotoxicity, cortical and subcortical neuronal damage as potential markers of HIV-associated neurocognitive disorder (HAND): A 1H-MRS and neuropsychological study', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Milan, ITALY, pp. 22 - 23, presented at 10th International Symposium on NeuroVirology, Milan, ITALY, 12 October 2010 - 16 October 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283409800048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Kandanearatchi A; Wilkinson J; Seddiki N; Zaunders J; Cunningham A; Brew BJ, 2010, 'Neurotropic HIV-1 viruses induce the Kynurenine Pathway (KP) more effectively compared to non-neurotropic viruses in monocyte derived dendritic cells (MDDCs)', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Milan, ITALY, pp. 43 - 43, presented at 10th International Symposium on NeuroVirology, Milan, ITALY, 12 October 2010 - 16 October 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283409800094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Clifford D; Brew BJ; Cinque P; Gorelik L; Bennett D; Panzara M; Duda P; Nath A, 2009, 'Design of a clinical trial of mefloquine in patients with progressive multifocal leukoencephalopathy', in Multiple Sclerosis, Arnold, London, England, pp. S87 - S87, presented at 25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Dusseldorf, GERMANY, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269652500255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2009
Tisch S; Brew BJ, 2009, 'Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', in MOVEMENT DISORDERS, WILEY-LISS, Paris, FRANCE, pp. S425 - S425, presented at 13th International Congress of Parkinsons Disease and Movement Disorders, Paris, FRANCE, 07 June 2009 - 11 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000266618101505&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Cysique LA; Brew BJ, 2009, 'HIV-associated neurocognitive impairment in the context undetectable plasma viral load', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 19 - 19, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 June 2009 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Pemberton LA; Sterjovski J; Ramsland P; Gorry PR; Brew BJ, 2009, 'Altered Structural Conformation of the V3 Region between CSF Isolates from HAD and Non-HAD Individuals: Implications for Co-Receptor Usage', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 71 - 72, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 June 2009 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Pemberton LA; Thompson K; Churchill M; Guillemin G; Gorry PR; Wesselingh S; Brew BJ, 2009, 'Mechanism for involvement of S-100 beta in HIV associated dementia', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 72 - 72, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 June 2009 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Gray LR; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherrief S; Wang B; Saksena N; Purcell DFJ; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR, 2009, 'Tissue-specific sequence alterations in the HIV-1 envelope favoring CCR5-usage contribute to persistence of dual-tropic virus in brain', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 31 - 32, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 June 2009 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Cysique LA; Maruff P; Wright E; Brew BJ, 2009, 'The effect of age in HIV-associated neurocognitive impairment before and after the era of combination therapy', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 19 - 20, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 June 2009 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Cysique LA; Brew BJ, 2009, 'HIV-associated neurocognitive impairment in the context undetectable plasma viral load', in Journal of Neurovirology, Taylor & Francis Inc, Philadelphia, PA, USA, pp. P42 - P42
2009
Cysique LA; Maruff P; Wright E; Brew BJ, 2008, 'The effect of age in HIV-associated neurocognitive impairment before and after the era of combination therapy', in Journal of Neurovirology, Taylor & Francis Inc, Philadelphia, PA, USA, pp. P43 - P43, presented at Petrophysics
2008
Guillemin GJ; Cullen KM; Smythe GA; Lim CK; Garner B; Brew BJ, 2008, 'Characterization of the kynurenine pathway in human primary neurons', in Proceedings of Aust Neuroscience Society, Australian Neuroscience Society 28th Annual Meeting, Hobart, pp. 78 - 78, presented at Australian Neuroscience Society 28th Annual Meeting, Hobart, 27 January 2008 - 30 January 2008
2008
Kandanearatchi A; Guillemin G; Wilkinson J; Cunningham A; Brew B, 2007, 'The kynurenine pathway metabolite quinolinic acid upregulates CCR5 expression', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, San Diego, CA, pp. 91 - 91, presented at 8th International Symposium on Neurovirology, San Diego, CA, 30 October 2007 - 02 November 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250754000172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2007
Brew BJ; Pemberton L; Thompson K; Gorry P; Wesselingh S, 2007, 'S-100b: Role in the pathogenesis of HIV associated dementia (HAD)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, Boston, MA, pp. A140 - A140, presented at 59th Annual Meeting of the American-Academy-of-Neurology, Boston, MA, 28 April 2007 - 05 May 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000245175001043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2007
Cinque P; Sidenius N; Bestetti A; Sala S; Lazzarin A; Brew BJ; Gisslen M-N; Hagberg L; Price RW, 2007, 'Cerebrospinal fluid (CSF) soluble urokinase plasminogen activator (uPA) receptor (suPAR) in AIDS dementia complex, and its relationships with other uPA, virological, immuneactivation and neuronal CSF markers', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, San Diego, CA, pp. 6 - 6, presented at 8th International Symposium on Neurovirology, San Diego, CA, 30 October 2007 - 02 November 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250754000009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2007
Brew BJ; Cysique LA; Maruff P, 2006, 'Variable benefit in neuropsychological function in HIV infected HAART-treated patients', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, San Diego, CA, pp. A257 - A257, presented at 58th Annual Meeting of the American-Academy-of-Neurology, San Diego, CA, 01 April 2006 - 08 April 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000236068103065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2006
Brew BJ, 1997, 'AIDS dementia complex and its prevention', in Antiviral Therapy, Int Medical Press Ltd, London, England, pp. 69 - 73, presented at ZERIT in the management of HIV disease, Cannes, France, 22 March 1997
1997
Brew BJ; Dunbar N; Pemberton LA; Kaldor JM, 1995, 'Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of B2microglobulin and neopterin', in Journal of Infectious Diseases, University of Chicago Press, Chicago, IL, pp. 294 - 298, presented at International Conference on AIDS in Asia and the Pacific, Chang Mai, Thailand, 17 September 1995 - 21 September 1995, http://dx.doi.org/10.1093/infdis/174.2.294
1995
Brew BJ, 1993, 'HIV-1-related neurological disease', in Journal of Acquired Immune Deficiency Syndromes, pp. S10 - S15
1993
Sweeney JA; Brew BJ; Keilp JG; Sidtis JJ; Price RW, 1991, 'Pursuit eye movement dysfunction in HIV-1 seropositive individuals.', in Journal of psychiatry & neuroscience : JPN, pp. 247 - 252
1991
HEYES MP; BREW BJ; PRICE RW; MARKEY SP, 1989, 'CEREBROSPINAL-FLUID QUINOLINIC ACID AND KYNURENIC ACID IN HIV-1 INFECTION', in GUIDOTTI A (ed.), NEUROTOXICITY OF EXCITATORY AMINO ACIDS, RAVEN PRESS, SCOTTSDALE, AZ, pp. 217 - 221, presented at SYMP ON NEUROTOXICITY OF EXCITATORY AMINO ACIDS, SCOTTSDALE, AZ, 26 October 1989 - 28 October 1989, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1990BS78Z00017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1989
Conference Presentations
add
Powell A; Sy J; Barnett Y; Mosalski S; Brew B; Fay K; Tomlinson S, 2018, 'POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN SKELETAL MUSCLE ARISING SEVEN YEARS AFTER ALLOGENEIC STEM CELL TRANSPLANT', Vol. 89, pp. E15 - E16, presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), Darwin, AUSTRALIA, 29 May 2018 - 01 June 2018, http://dx.doi.org/10.1136/jnnp-2018-ANZAN.36
2018
Books
add
Brew BJ, 2001, HIV Neurology, 3rd Edition, Oxford University Press, New York
2001
Brew BJ; Portegies P, 1997, A practical guide to the pathogenesis and treatment of HIV CNS disease, Original, London
1997
Book Chapters
add
Massey J; Brew B, 2017, 'Global issues in neuroAIDS', in Global Virology II - HIV and NeuroAIDS, pp. 21 - 42, http://dx.doi.org/10.1007/978-1-4939-7290-6_2
2017
Jones SP; Guillemin GJ; Brew BJ, 2015, 'Chapter 20: Role of the kynurenine pathway in stem cell biology', in Targeting the Broadly Pathogenic Kynurenine Pathway, Springer, pp. 257 - 272, http://dx.doi.org/10.1007/978-3-319-11870-3_20
2015
Davies NWS; Brew BJ, 2014, 'Clinical Aspects of HIV-Related Neurocognitive Disorders', in HIV and Psychiatry, pp. 107 - 156, http://dx.doi.org/10.1002/9781118339503.ch3
2014
Cruse B; Brew BJ, 2014, 'Excitotoxicity in HIV associated neurocognitive disorders', in Handbook of Neurotoxicity, pp. 1247 - 1265, http://dx.doi.org/10.1007/978-1-4614-5836-4_143
2014
Davies NP; Brew BJ, 2011, 'The pathobiology of HIV related neuropathies', in Gendelman HE (ed.), Cognitive Neurology: a clinical textbook, edn. 3rd edition, Oxford University Press, Oxford
2011
Davies NWS; Brew BJ, 2011, 'Dizziness in someone with HIV', in Case Studies in Dementia: Common and Uncommon Presentations, pp. 180 - 187, http://dx.doi.org/10.1017/CBO9780511997433.026
2011
Gisslen M; Hagberg L; Cinque P; Brew B; Price RW, 2009, 'Cerebrospinal Fluid Markers in the Management of Central Nervous System HIV Infection and the AIDS Dementia Complex', in Goodkin K; Shapshak P; Verma A (ed.), SPECTRUM OF NEURO-AIDS DISORDERS: PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENT, AMER SOC MICROBIOLOGY, pp. 173 - 179, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279006800014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Paul R; Sacktor N; Cysique LA; Brew BJ; Valcour V, 2009, 'Impact of clade diversity on neuropsychological outcomes', in Paul R; Sacktor N; Valcour V; Tashima K (ed.), HIV and the Brain: New Challenges in the Modern Era, edn. 1st, Humana Press Inc, Totowa, pp. 319 - 330
2009
Cysique LA; Brew BJ, 2009, 'The assessment of HIV-associated neurocognitive disorders: New challenges in the HAART era', in Paul R; Sacktor N; Valcour V; Tashima K (ed.), HIV and the Brain: New Challenges in the Modern Era, edn. 1st, Humana Press Inc, Totowa, pp. 109 - 132
2009
Brew BJ, 2009, 'Global Issues in Neuro-AIDS and Their Evolution over the Future of the HAART Era', in Goodkin K; Shapshak P; Verma A (ed.), SPECTRUM OF NEURO-AIDS DISORDERS: PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENT, AMER SOC MICROBIOLOGY, pp. 507 - 523, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279006800037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Loy CT; Tomlinson S; Brew BJ, 2005, 'HIV-related neurological disease in the era of HAART', in Emerging Neurological Infections, pp. 427 - 452
2005
Brew BJ, 2002, 'Neurological manaifestations of HIV Infection', in Crowe S; Hoy J; Mills J (ed.), Management of the HIV-infected Patient (2nd Ed), edn. Original, Martin Dunitz, London, UK, pp. 161 - 182
2002
Brew BJ, 1996, 'Neurological manifestations of HIV infection', in Management of the HIV-infected Patient, edn. Original, Cambridge University Press, Cambridge, pp. 109 - 124
1996
Brew BJ, 1996, 'Neurologic manifestations of HIV infection', in Management of the HIV-infected Patient, edn. Original, Cambridge University Press, Cambridge, pp. 109 - 124
1996
Conference Posters
add
Gates T; Cysique LA; Chaganti J; Siefried KJ; Brew BJ, 2015, 'Maraviroc-enhanced CART improves cognition in virally suppressed HAND: a pilot study', Seattle, USA, presented at The 22nd Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, USA, 23 February 2015 - 26 February 2015
2015
Lu G; Siefried KJ; Draper B; Brew BJ; Cysique LA, 2013, 'Moderate neurocognitive decline can be detected over a four-month period using the HIV-dementia scale (HDS)', Atlanta, USA, presented at The 20th Conference on Retroviruses and Opportunistic Infections (CROI), Atlanta, USA, 03 March 2013 - 06 March 2013
2013